Distributions of all expression values and Top 1% of expressed KnownJunction features for libraries: PreTx, PostTx
Download data matrix file (KnownJunction x library): KnownJunctionExpression_v53.txt.gz
Distribution of log2 expression values for library: PreTx and data type: KnownJunction
Distribution of all expression values for the feature type: KnownJunction. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: PostTx and data type: KnownJunction
Distribution of all expression values for the feature type: KnownJunction. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Top 1% of expressed KnownJunction features
The following table provides a ranked list of the most highly expressed KnownJunction features. Each column corresponds to an expression library. Each table cell contains the Gene Name (which links to the ALEXA-Seq gene record), followed by the Feature Name (which links to the feature's coordinates in the UCSC Genome Browser and displays expression data), the log2 expression value 'Exp' for the feature, and the percent expression value '% Exp' ([feature expression/gene expression]*100). For Gene records the percent displayed here represents the percentage of all reads for the library instead. Features that are NOT supported by an EST/mRNA sequence are indicated in bold. For exon junction features the number of exons skipped by the junction is indicated as 'Sn', where n is the number of exons skipped (e.g. S0 means no exons skipped, S1 means one exon skipped, etc.).
| RANK | PreTx (Gene | Feature | Exp | % Exp) | PostTx (Gene | Feature | Exp | % Exp) |
| 1 | EEF1A1 | E3a_E3c (S0) | 18.63 | 1263.69% | EEF1A1 | E3a_E3c (S0) | 18.95 | 1156.86% |
| 2 | RPS27 | E1a_E3a (S1) | 17.76 | 522.82% | EEF1A1 | E3b_E4a (S0) | 18.27 | 721.20% |
| 3 | RPL26 | E1a_E2a (S0) | 17.41 | 302.33% | RPS27 | E1a_E3a (S1) | 18.19 | 518.68% |
| 4 | RPS11 | E1a_E2a (S0) | 17.35 | 286.34% | RPS11 | E1a_E2a (S0) | 18.10 | 267.22% |
| 5 | CD74 | E5a_E6a (S0) | 17.08 | 65.37% | RPS14 | E1a_E2a (S0) | 17.91 | 888.89% |
| 6 | RPS14 | E1a_E2a (S0) | 16.97 | 963.52% | RPL26 | E1a_E2a (S0) | 17.86 | 280.08% |
| 7 | RPS18 | E1a_E2a (S0) | 16.89 | 203.10% | RPS18 | E1a_E2a (S0) | 17.58 | 162.58% |
| 8 | RPL23 | E1a_E3a (S1) | 16.67 | 370.90% | RPL37A | E1a_E2a (S0) | 17.32 | 213.43% |
| 9 | ACTB | E3a_E4a (S0) | 16.66 | 49.03% | RPL39 | E1a_E2a (S0) | 17.08 | 142.37% |
| 10 | RPL37A | E1a_E2a (S0) | 16.62 | 227.47% | RPL34 | E3a_E4a (S0) | 17.04 | 301.05% |
| 11 | ACTB | E5a_E6a (S0) | 16.51 | 44.01% | RPL23 | E1a_E3a (S1) | 16.81 | 339.82% |
| 12 | RPL35A | E1a_E2a (S0) | 16.46 | 226.28% | RPL26 | E2a_E3a (S0) | 16.79 | 133.10% |
| 13 | CD74 | E4a_E5a (S0) | 16.45 | 42.33% | RPL35A | E1a_E2a (S0) | 16.74 | 183.66% |
| 14 | EEF1A1 | E3b_E4a (S0) | 16.43 | 274.40% | RPS4X | E1a_E2a (S0) | 16.71 | 143.32% |
| 15 | RPS11 | E3a_E4a (S0) | 16.39 | 146.83% | RPL29 | E1a_E2a (S0) | 16.68 | 222.28% |
| 16 | RPS4X | E1a_E2a (S0) | 16.37 | 158.39% | RPS18 | E3a_E4a (S0) | 16.68 | 87.02% |
| 17 | CD74 | E6a_E8a (S1) | 16.34 | 39.02% | RPS20 | E2a_E3a (S0) | 16.65 | 140.09% |
| 18 | ACTB | E4a_E5a (S0) | 16.23 | 36.35% | RPL35 | E1a_E2a (S0) | 16.54 | 203.13% |
| 19 | RPL30 | E3a_E4a (S0) | 16.20 | 168.25% | RPS6 | E3a_E4a (S0) | 16.51 | 160.46% |
| 20 | RPS23 | E1a_E2a (S0) | 16.17 | 941.66% | TPT1 | E2a_E3a (S0) | 16.51 | 135.08% |
| 21 | RPL39 | E1a_E2a (S0) | 16.09 | 144.74% | RPL30 | E3a_E4a (S0) | 16.51 | 155.55% |
| 22 | RPL10 | E5a_E6a (S0) | 15.99 | 419.45% | RPS19 | E1a_E2a (S0) | 16.45 | 276.70% |
| 23 | CD74 | E2a_E3a (S0) | 15.96 | 30.05% | RPS15 | E1a_E2a (S0) | 16.45 | 191.46% |
| 24 | RPL24 | E3a_E4a (S0) | 15.95 | 279.63% | TPT1 | E1b_E2a (S0) | 16.43 | 127.28% |
| 25 | RPS18 | E3a_E4a (S0) | 15.92 | 103.55% | RPL24 | E1a_E2a (S0) | 16.43 | 213.67% |
| 26 | CD74 | E3a_E4a (S0) | 15.91 | 29.02% | TPT1 | E3a_E4a (S0) | 16.40 | 124.71% |
| 27 | ACTG1 | E5a_E6a (S0) | 15.90 | 78.69% | RPL36 | E1a_E2b (S0) | 16.38 | 289.20% |
| 28 | RPL23 | E4a_E5a (S0) | 15.87 | 213.19% | RPL32 | E1a_E2c (S0) | 16.36 | 464.42% |
| 29 | CD74 | E8a_E10a (S1) | 15.84 | 27.74% | RPL27 | E1a_E2a (S0) | 16.36 | 128.88% |
| 30 | RPS15 | E1a_E2a (S0) | 15.83 | 195.42% | RPS23 | E1a_E2a (S0) | 16.32 | 802.06% |
| 31 | RPL29 | E1a_E2a (S0) | 15.80 | 228.50% | RPL24 | E3a_E4a (S0) | 16.30 | 195.41% |
| 32 | RPLP2 | E3a_E4a (S0) | 15.79 | 129.98% | CD74 | E5a_E6a (S0) | 16.29 | 54.37% |
| 33 | RPL35A | E3a_E4a (S0) | 15.76 | 140.06% | RPS12 | E1a_E2a (S0) | 16.20 | 136.83% |
| 34 | RPS19 | E1a_E2a (S0) | 15.74 | 290.67% | RPL35A | E3a_E4a (S0) | 16.16 | 123.15% |
| 35 | RPL32 | E1a_E2c (S0) | 15.72 | 493.45% | TPT1 | E4a_E5a (S0) | 16.14 | 104.73% |
| 36 | RPS15A | E3a_E4a (S0) | 15.70 | 160.66% | CD74 | E4a_E5a (S0) | 16.13 | 48.43% |
| 37 | RPL27 | E1a_E2a (S0) | 15.62 | 143.99% | ACTB | E3a_E4a (S0) | 16.12 | 52.58% |
| 38 | RPL24 | E1a_E2a (S0) | 15.57 | 215.62% | RPS7 | E1a_E2a (S1) | 16.11 | 287.82% |
| 39 | RPS24 | E1a_E2a (S0) | 15.51 | 253.67% | RPL10 | E5a_E6a (S0) | 16.01 | 369.68% |
| 40 | TPT1 | E3a_E4a (S0) | 15.48 | 116.34% | RPS12 | E3a_E4a (S0) | 15.97 | 116.58% |
| 41 | ARHGDIB | E2a_E3a (S0) | 15.47 | 179.02% | RPL18 | E1a_E2a (S0) | 15.93 | 162.84% |
| 42 | RPL18 | E1a_E2a (S0) | 15.47 | 178.51% | CD74 | E6a_E8a (S1) | 15.86 | 40.20% |
| 43 | TPT1 | E2a_E3a (S0) | 15.47 | 115.34% | RPLP0 | E1a_E2b (S0) | 15.84 | 98.19% |
| 44 | TPT1 | E4a_E5a (S0) | 15.40 | 110.18% | RPS21 | E1b_E2b (S0) | 15.73 | 380.15% |
| 45 | RPS20 | E2a_E3a (S0) | 15.32 | 119.20% | RPS27A | E4a_E5a (S0) | 15.72 | 141.48% |
| 46 | RPS12 | E1a_E2a (S0) | 15.31 | 161.99% | CD74 | E2a_E3a (S0) | 15.69 | 35.93% |
| 47 | RPLP0 | E1a_E2b (S0) | 15.31 | 119.05% | RPS24 | E1a_E2a (S0) | 15.69 | 218.51% |
| 48 | RPS6 | E3a_E4a (S0) | 15.30 | 142.78% | ACTB | E5a_E6a (S0) | 15.67 | 38.51% |
| 49 | RPL36 | E1a_E2b (S0) | 15.29 | 281.94% | ACTB | E4a_E5a (S0) | 15.67 | 38.50% |
| 50 | ACTB | E2a_E3a (S0) | 15.29 | 18.90% | RPS14 | E2a_E3a (S0) | 15.66 | 187.66% |
| 51 | IGHV4-31 | E2a_E3a (S0) | 15.20 | 48.24% | RPS6 | E2a_E2e (S0) | 15.64 | 87.49% |
| 52 | RPS8 | E3b_E4a (S0) | 15.18 | 104.66% | B2M | E2a_E3a (S0) | 15.61 | 31.11% |
| 53 | RPL4 | E2a_E3a (S0) | 15.17 | 87.95% | RPS6 | E2e_E3a (S0) | 15.61 | 85.65% |
| 54 | RPL19 | E1a_E2a (S0) | 15.15 | 97.74% | ACTB | E2a_E3a (S0) | 15.60 | 36.77% |
| 55 | B2M | E2a_E3a (S0) | 15.10 | 28.54% | ACTG1 | E5a_E6a (S0) | 15.55 | 86.21% |
| 56 | RPL35 | E1a_E2a (S0) | 15.08 | 193.05% | UBA52 | E2a_E3a (S0) | 15.54 | 183.02% |
| 57 | RPL37A | E3a_E4a (S0) | 15.03 | 75.84% | FAU | E2a_E3a (S0) | 15.54 | 162.32% |
| 58 | ACTG1 | E3a_E4a (S0) | 15.02 | 42.73% | RPL19 | E1a_E2a (S0) | 15.53 | 92.23% |
| 59 | RPS27A | E4a_E5a (S0) | 15.02 | 215.49% | RPS19 | E3a_E4a (S0) | 15.51 | 143.72% |
| 60 | UBA52 | E2a_E3a (S0) | 14.99 | 161.68% | CD74 | E8a_E10a (S1) | 15.50 | 31.41% |
| 61 | RPL22 | E1a_E2a (S0) | 14.95 | 480.75% | EEF1A1 | E8a_E9a (S0) | 15.47 | 103.59% |
| 62 | HNRNPH2 | E1a_E2a (S0) | 14.94 | 955.96% | RPLP2 | E3a_E4a (S0) | 15.46 | 76.48% |
| 63 | RPL10A | E1a_E2a (S0) | 14.94 | 137.38% | RPS8 | E3b_E4a (S0) | 15.43 | 67.32% |
| 64 | IGHV4-31 | E3a_E4a (S0) | 14.83 | 37.48% | CD74 | E3a_E4a (S0) | 15.43 | 29.94% |
| 65 | EEF1G | E4a_E5a (S0) | 14.81 | 95.76% | EEF1A1 | E5c_E6a (S0) | 15.41 | 99.33% |
| 66 | GAPDH | E7a_E8a (S0) | 14.81 | 80.08% | RPS23 | E2a_E3a (S0) | 15.41 | 425.55% |
| 67 | ACTG1 | E4a_E5a (S0) | 14.79 | 36.31% | EEF1A1 | E4b_E5a (S0) | 15.39 | 97.74% |
| 68 | RPL19 | E3a_E4a (S0) | 14.79 | 76.04% | RPS3 | E1a_E2a (S0) | 15.37 | 65.00% |
| 69 | RPLP1 | E2a_E3a (S0) | 14.77 | 59.94% | RPS3A | E2a_E3a (S0) | 15.33 | 131.49% |
| 70 | FAU | E2a_E3a (S0) | 14.77 | 178.92% | GAPDH | E4a_E5a (S0) | 15.30 | 100.87% |
| 71 | RPL18 | E3a_E4a (S0) | 14.75 | 108.11% | RPL10A | E1a_E2a (S0) | 15.24 | 107.09% |
| 72 | HLA-B | E6a_E7a (S0) | 14.74 | 89.51% | RPLP1 | E1a_E2a (S0) | 15.22 | 49.12% |
| 73 | NACA | E1a_E2a (S0) | 14.70 | 226.73% | RPS21 | E3b_E3d (S0) | 15.22 | 265.20% |
| 74 | IGHV4-31 | E1a_E2a (S0) | 14.69 | 33.85% | RPS3 | E2a_E3a (S0) | 15.21 | 58.19% |
| 75 | HLA-DRA | E3a_E4a (S0) | 14.66 | 37.34% | RPL10 | E7a_E8a (S0) | 15.20 | 211.10% |
| 76 | GAPDH | E1a_E2b (S0) | 14.65 | 72.09% | HNRNPH2 | E1a_E2a (S0) | 15.19 | 1137.55% |
| 77 | IGHM | E1a_E2a (S0) | 14.63 | 41.09% | RPL14 | E3a_E4a (S0) | 15.19 | 242.95% |
| 78 | RPL11 | E3a_E4a (S0) | 14.62 | 57.19% | GNB2L1 | E1a_E2a (S0) | 15.15 | 70.21% |
| 79 | RPL10 | E7a_E8a (S0) | 14.62 | 162.39% | RPS15A | E3a_E4a (S0) | 15.13 | 43.37% |
| 80 | HLA-B | E4a_E5a (S0) | 14.61 | 81.55% | RPS6 | E4a_E5a (S0) | 15.12 | 61.04% |
| 81 | PFN1 | E2a_E3a (S0) | 14.59 | 58.50% | RPS4X | E3a_E4a (S0) | 15.11 | 47.35% |
| 82 | TPT1 | E1b_E2a (S0) | 14.57 | 61.97% | MYL6 | E3a_E4a (S0) | 15.07 | 142.40% |
| 83 | RPS4X | E6a_E7a (S0) | 14.54 | 44.48% | RPS4X | E6a_E7a (S0) | 15.05 | 45.66% |
| 84 | AF235103.4 | E1a_E3a (S1) | 14.53 | 106.97% | RPS18 | E4a_E5a (S0) | 15.05 | 28.17% |
| 85 | RPL4 | E6a_E7a (S0) | 14.53 | 56.14% | RPS29 | E2a_E3a (S0) | 15.03 | 53.21% |
| 86 | RPS6 | E2a_E2e (S0) | 14.52 | 83.28% | NACA | E1a_E2a (S0) | 15.02 | 205.90% |
| 87 | HLA-DRA | E4a_E5a (S0) | 14.51 | 33.75% | ACTG1 | E4a_E5a (S0) | 15.02 | 59.59% |
| 88 | RPL7A | E1a_E3a (S1) | 14.51 | 1353.77% | GAPDH | E7a_E8a (S0) | 15.00 | 82.45% |
| 89 | C4orf7 | E1a_E2a (S0) | 14.45 | 87.40% | RPL19 | E5a_E6a (S0) | 14.98 | 63.30% |
| 90 | RPS7 | E1a_E2a (S1) | 14.45 | 313.65% | HNRNPH2 | E3a_E4a (S0) | 14.93 | 950.54% |
| 91 | RPS3 | E1a_E2a (S0) | 14.42 | 75.37% | RPS16 | E2a_E3a (S0) | 14.91 | 72.85% |
| 92 | EEF1A1 | E5c_E6a (S0) | 14.42 | 68.04% | RPL22 | E1a_E2a (S0) | 14.89 | 461.74% |
| 93 | TIMP1 | E1a_E3a (S1) | 14.39 | 201.38% | IGHM | E1a_E2a (S0) | 14.87 | 37.74% |
| 94 | RPL10 | E6a_E7a (S0) | 14.39 | 138.16% | RPL7A | E1a_E3a (S1) | 14.86 | 1376.44% |
| 95 | RPS4X | E3a_E4a (S0) | 14.37 | 39.56% | RPL18 | E3a_E4a (S0) | 14.86 | 77.47% |
| 96 | GAPDH | E5a_E6a (S0) | 14.36 | 58.88% | RPS2 | E5a_E6a (S0) | 14.84 | 71.25% |
| 97 | RPL4 | E5a_E6a (S0) | 14.36 | 49.85% | MYL6 | E1a_E2a (S0) | 14.84 | 121.05% |
| 98 | RPS6 | E2e_E3a (S0) | 14.32 | 72.42% | RPS6 | E2c_E2f (S0) | 14.83 | 49.90% |
| 99 | RPL34 | E3a_E4a (S0) | 14.30 | 87.46% | AF235103.4 | E1a_E3a (S1) | 14.82 | 89.73% |
| 100 | HLA-DRA | E2a_E3a (S0) | 14.26 | 28.39% | RPS4X | E4a_E6a (S1) | 14.82 | 38.76% |
| 101 | RPL14 | E3a_E4a (S0) | 14.26 | 173.36% | HLA-B | E6a_E7a (S0) | 14.79 | 94.94% |
| 102 | RPL4 | E8a_E9a (S0) | 14.25 | 46.34% | ACTG1 | E3a_E4a (S0) | 14.77 | 50.35% |
| 103 | MYL6 | E1a_E2a (S0) | 14.25 | 133.51% | RPS8 | E5a_E6a (S0) | 14.75 | 41.97% |
| 104 | PABPC1 | E7a_E8a (S0) | 14.22 | 71.33% | GNB2L1 | E2a_E3a (S0) | 14.74 | 53.00% |
| 105 | EEF2 | E8a_E9a (S0) | 14.20 | 58.94% | RPS10 | E3a_E4a (S0) | 14.73 | 43.94% |
| 106 | IGHM | E3a_E4a (S0) | 14.19 | 30.25% | RPS10 | E2a_E3a (S0) | 14.72 | 43.52% |
| 107 | FTL | E3a_E4a (S0) | 14.18 | 43.17% | MS4A1 | E4a_E5a (S0) | 14.72 | 63.82% |
| 108 | RPS21 | E1b_E2b (S0) | 14.17 | 381.23% | MS4A1 | E6a_E7a (S0) | 14.71 | 63.72% |
| 109 | RPL26 | E2a_E3a (S0) | 14.16 | 31.65% | RPLP0 | E6a_E7a (S0) | 14.69 | 44.05% |
| 110 | TIMP1 | E4a_E5a (S0) | 14.15 | 170.85% | RPS13 | E1a_E2a (S0) | 14.69 | 44.67% |
| 111 | RPL13 | E5a_E6a (S0) | 14.15 | 84.12% | HLA-DRA | E3a_E4a (S0) | 14.69 | 36.21% |
| 112 | APOE | E1a_E2a (S0) | 14.14 | 175.89% | HLA-DRA | E4a_E5a (S0) | 14.67 | 35.96% |
| 113 | RPS2 | E5a_E6a (S0) | 14.14 | 50.42% | IGHM | E3a_E4a (S0) | 14.67 | 32.92% |
| 114 | VIM | E6a_E7a (S0) | 14.14 | 65.44% | ACTG1 | E2a_E3a (S0) | 14.66 | 46.69% |
| 115 | RPL35 | E3a_E5a (S1) | 14.13 | 99.85% | RPS16 | E3a_E3b (S0) | 14.65 | 61.12% |
| 116 | HLA-DRA | E1a_E2a (S0) | 14.09 | 25.08% | RPL4 | E6a_E7a (S0) | 14.65 | 64.87% |
| 117 | RPS4X | E4a_E6a (S1) | 14.08 | 32.51% | RPL5 | E5a_E6a (S0) | 14.64 | 51.89% |
| 118 | RPL6 | E2a_E3a (S0) | 14.08 | 50.25% | RPS25 | E1a_E2a (S0) | 14.64 | 31.64% |
| 119 | HLA-DPB1 | E8a_E9a (S0) | 14.07 | 120.24% | RPL12 | E2a_E3a (S0) | 14.62 | 77.69% |
| 120 | FAU | E4a_E5a (S0) | 14.05 | 108.95% | RPL13 | E5a_E6a (S0) | 14.61 | 90.84% |
| 121 | PFN1 | E1a_E2a (S0) | 14.03 | 39.48% | RPLP0 | E7a_E8a (S0) | 14.60 | 41.34% |
| 122 | RPL19 | E4a_E5a (S0) | 14.02 | 44.82% | HLA-B | E4a_E5a (S0) | 14.58 | 82.35% |
| 123 | ACTG1 | E2a_E3a (S0) | 14.02 | 21.28% | RPS27A | E5a_E6a (S0) | 14.58 | 64.55% |
| 124 | GAPDH | E6a_E7a (S0) | 14.01 | 46.29% | RPL10 | E6a_E7a (S0) | 14.58 | 137.10% |
| 125 | FTL | E2a_E3a (S0) | 14.01 | 38.52% | RPS11 | E3a_E4a (S0) | 14.56 | 23.02% |
| 126 | GNB2L1 | E3a_E4a (S0) | 14.00 | 38.88% | RPLP0 | E5a_E6a (S0) | 14.56 | 40.28% |
| 127 | HLA-B | E13a_E14b (S0) | 13.99 | 53.08% | RPS23 | E3a_E4a (S0) | 14.54 | 232.40% |
| 128 | VIM | E8a_E9a (S0) | 13.98 | 58.80% | RPS2 | E2a_E3a (S0) | 14.52 | 57.32% |
| 129 | RPL6 | E4a_E5a (S0) | 13.98 | 46.74% | RPL19 | E3a_E4a (S0) | 14.52 | 45.80% |
| 130 | RPS2 | E6a_E7a (S0) | 13.97 | 44.73% | GAPDH | E1a_E2b (S0) | 14.50 | 58.32% |
| 131 | EEF2 | E7a_E8a (S0) | 13.97 | 49.95% | RPL11 | E4a_E5a (S0) | 14.50 | 35.12% |
| 132 | GNB2L1 | E5a_E6a (S0) | 13.96 | 37.74% | HLA-DRA | E2a_E3a (S0) | 14.48 | 31.44% |
| 133 | EEF1G | E7a_E8a (S0) | 13.96 | 52.91% | RPL19 | E4a_E5a (S0) | 14.48 | 44.62% |
| 134 | EEF2 | E6a_E7a (S0) | 13.95 | 49.59% | RPL31 | E1a_E1e (S0) | 14.48 | 2565.27% |
| 135 | GNB2L1 | E6a_E7a (S0) | 13.95 | 37.50% | RPS3 | E5a_E6a (S0) | 14.47 | 34.97% |
| 136 | GAPDH | E4a_E5a (S0) | 13.94 | 44.04% | RPL11 | E3a_E4a (S0) | 14.46 | 34.03% |
| 137 | VIM | E4a_E5a (S0) | 13.93 | 56.68% | RPL10A | E4a_E5a (S0) | 14.44 | 61.50% |
| 138 | HLA-B | E7a_E8a (S0) | 13.92 | 50.73% | RPS11 | E2a_E3a (S0) | 14.41 | 20.78% |
| 139 | EEF1A1 | E8a_E9a (S0) | 13.91 | 47.98% | RPS11 | E4a_E5a (S0) | 14.40 | 20.56% |
| 140 | RPL4 | E1a_E2a (S0) | 13.91 | 36.61% | TMSB10 | E1a_E2a (S0) | 14.37 | 38.42% |
| 141 | ARHGDIB | E1a_E2a (S0) | 13.90 | 60.09% | GNB2L1 | E6a_E7a (S0) | 14.36 | 40.85% |
| 142 | RPS25 | E1a_E2a (S0) | 13.89 | 21.25% | MS4A1 | E3a_E4a (S0) | 14.35 | 49.53% |
| 143 | GNB2L1 | E2a_E3a (S0) | 13.89 | 35.85% | RPLP0 | E4a_E5a (S0) | 14.34 | 34.74% |
| 144 | RPS6 | E4a_E5a (S0) | 13.88 | 53.27% | IGJ | E2a_E3a (S0) | 14.32 | 135.84% |
| 145 | PABPC1 | E5a_E6a (S0) | 13.86 | 55.75% | RPL5 | E4a_E5a (S0) | 14.31 | 41.16% |
| 146 | EEF2 | E5a_E6a (S0) | 13.86 | 46.46% | RPL4 | E5a_E6a (S0) | 14.30 | 50.96% |
| 147 | EEF2 | E9a_E10a (S0) | 13.85 | 46.09% | RPS18 | E5a_E6a (S0) | 14.30 | 16.69% |
| 148 | SERF2 | E3a_E4b (S0) | 13.85 | 1314.26% | RPL5 | E7a_E8a (S0) | 14.29 | 40.86% |
| 149 | RPL6 | E6a_E7a (S0) | 13.84 | 42.49% | RPS4X | E7a_E8a (S0) | 14.29 | 26.94% |
| 150 | HLA-E | E6a_E7a (S0) | 13.83 | 75.69% | GNB2L1 | E5a_E6a (S0) | 14.29 | 38.82% |
| 151 | RPSA | E1a_E2a (S0) | 13.83 | 229.10% | RPL4 | E8a_E9a (S0) | 14.28 | 50.08% |
| 152 | GNB2L1 | E4a_E5a (S0) | 13.82 | 34.35% | RPS14 | E4a_E5a (S0) | 14.26 | 71.14% |
| 153 | HLA-DRB1 | E4a_E5a (S0) | 13.80 | 85.31% | GNB2L1 | E3a_E4a (S0) | 14.26 | 37.93% |
| 154 | RPLP0 | E5a_E6a (S0) | 13.79 | 41.56% | RPL15 | E3a_E4a (S0) | 14.24 | 131.61% |
| 155 | RPL13 | E4a_E5a (S0) | 13.78 | 65.12% | HLA-DRA | E1a_E2a (S0) | 14.24 | 26.65% |
| 156 | LAPTM5 | E2a_E3a (S0) | 13.77 | 55.97% | RPLP0 | E3a_E4a (S0) | 14.24 | 32.31% |
| 157 | EIF4A1 | E3a_E4c (S0) | 13.77 | 614.96% | HLA-B | E7a_E8a (S0) | 14.24 | 64.70% |
| 158 | EEF1G | E6a_E7a (S0) | 13.76 | 46.12% | PFN1 | E2a_E3a (S0) | 14.22 | 64.00% |
| 159 | RPL11 | E4a_E5a (S0) | 13.75 | 31.35% | RPL6 | E5a_E6a (S0) | 14.22 | 43.23% |
| 160 | LAPTM5 | E4a_E5a (S0) | 13.73 | 54.57% | RPL10A | E5a_E6a (S0) | 14.22 | 52.66% |
| 161 | RPS10 | E3a_E4a (S0) | 13.72 | 52.09% | RPL6 | E4a_E5a (S0) | 14.21 | 42.89% |
| 162 | RPL5 | E5a_E6a (S0) | 13.72 | 53.82% | RPS2 | E6a_E7a (S0) | 14.20 | 45.93% |
| 163 | PABPC1 | E6a_E7a (S0) | 13.72 | 50.37% | RPS12 | E4a_E5a (S0) | 14.20 | 34.10% |
| 164 | EEF1G | E8a_E9a (S0) | 13.71 | 44.53% | GNB2L1 | E4a_E5a (S0) | 14.20 | 36.42% |
| 165 | RPLP0 | E6a_E7a (S0) | 13.71 | 39.34% | GAPDH | E6a_E7a (S0) | 14.18 | 46.57% |
| 166 | RPLP0 | E4a_E5a (S0) | 13.71 | 39.29% | RPL4 | E9a_E10a (S0) | 14.16 | 46.08% |
| 167 | EEF2 | E4a_E5a (S0) | 13.68 | 40.96% | B2M | E1a_E2a (S0) | 14.15 | 11.30% |
| 168 | RPLP0 | E7a_E8a (S0) | 13.68 | 38.50% | RPS27 | E3a_E3b (S0) | 14.15 | 31.43% |
| 169 | RPL6 | E5a_E6a (S0) | 13.68 | 37.91% | RPS8 | E4a_E5a (S0) | 14.14 | 27.55% |
| 170 | AC100778.5 | E3a_E4a (S0) | 13.67 | 617.77% | RPS14 | E3a_E4a (S0) | 14.11 | 63.95% |
| 171 | UQCRB | E1a_E2a (S0) | 13.67 | 379.94% | RPSA | E1a_E2a (S0) | 14.10 | 187.15% |
| 172 | GNB2L1 | E1a_E2a (S0) | 13.67 | 30.85% | RPS3 | E4a_E5a (S0) | 14.09 | 26.81% |
| 173 | RPS8 | E5a_E6a (S0) | 13.67 | 36.77% | RPL4 | E2a_E3a (S0) | 14.08 | 43.89% |
| 174 | PABPC1 | E2a_E3a (S0) | 13.66 | 48.30% | EEF1G | E7a_E8a (S0) | 14.08 | 55.25% |
| 175 | EEF2 | E10a_E11a (S0) | 13.65 | 40.22% | RPL27 | E3a_E4a (S0) | 14.07 | 26.52% |
| 176 | RPS21 | E3b_E3d (S0) | 13.65 | 264.39% | RPL27A | E4a_E5a (S0) | 14.07 | 508.04% |
| 177 | HLA-E | E7a_E8a (S0) | 13.64 | 66.40% | RPL6 | E6a_E7a (S0) | 14.07 | 38.76% |
| 178 | RPS12 | E3a_E4a (S0) | 13.64 | 50.96% | CD37 | E2a_E3a (S0) | 14.06 | 95.21% |
| 179 | LAPTM5 | E5a_E6a (S0) | 13.64 | 51.10% | EEF2 | E8a_E9a (S0) | 14.03 | 61.12% |
| 180 | VIM | E7a_E8a (S0) | 13.64 | 46.24% | ATP5G2 | E1b_E2a (S0) | 14.02 | 288.77% |
| 181 | VIM | E5a_E6a (S0) | 13.63 | 45.99% | RPLP2 | E2a_E3a (S0) | 14.02 | 28.21% |
| 182 | HNRNPH2 | E3a_E4a (S0) | 13.63 | 383.59% | RPS20 | E3a_E4a (S0) | 14.02 | 22.63% |
| 183 | PABPC1 | E3a_E4a (S0) | 13.63 | 47.31% | RPLP1 | E2a_E3a (S0) | 14.01 | 21.30% |
| 184 | HLA-E | E3a_E4a (S0) | 13.61 | 64.90% | RPL13A | E5a_E6a (S0) | 14.00 | 31.53% |
| 185 | RPS4X | E7a_E8a (S0) | 13.60 | 23.19% | MS4A1 | E5a_E6a (S0) | 13.99 | 38.48% |
| 186 | PABPC1 | E4a_E5a (S0) | 13.59 | 46.03% | RPL4 | E1a_E2a (S0) | 13.97 | 40.54% |
| 187 | RPL4 | E9a_E10a (S0) | 13.56 | 28.71% | RPS18 | E2a_E3a (S0) | 13.93 | 12.95% |
| 188 | HLA-B | E3a_E4a (S0) | 13.55 | 39.37% | SERF2 | E3a_E4b (S0) | 13.93 | 1046.57% |
| 189 | RPS13 | E1a_E2a (S0) | 13.55 | 44.34% | UQCRB | E1a_E2a (S0) | 13.92 | 322.73% |
| 190 | PABPC1 | E9b_E10a (S0) | 13.54 | 44.49% | MS4A1 | E2a_E3a (S0) | 13.92 | 36.78% |
| 191 | CFL1 | E2a_E3a (S0) | 13.54 | 46.67% | TOMM7 | E3a_E5a (S1) | 13.88 | 237.35% |
| 192 | ATP5G2 | E1b_E2a (S0) | 13.53 | 310.92% | ATP5E | E2a_E2b (S0) | 13.87 | 396.36% |
| 193 | HLA-DPA1 | E5a_E6a (S0) | 13.53 | 48.96% | RPS13 | E5a_E6a (S0) | 13.87 | 25.36% |
| 194 | MS4A1 | E4a_E5a (S0) | 13.52 | 55.81% | RPL35A | E2a_E3a (S0) | 13.86 | 25.00% |
| 195 | PABPC1 | E12a_E13a (S0) | 13.52 | 43.92% | GAPDH | E9a_E10a (S0) | 13.85 | 37.12% |
| 196 | PABPC1 | E8a_E9a (S0) | 13.52 | 43.83% | RPL18 | E4a_E5a (S0) | 13.85 | 38.50% |
| 197 | VIM | E3a_E4a (S0) | 13.50 | 42.14% | EEF1G | E6a_E7a (S0) | 13.83 | 46.26% |
| 198 | MS4A1 | E6a_E7a (S0) | 13.50 | 54.96% | TMSB4X | E1d_E2a (S0) | 13.82 | 36.58% |
| 199 | RPL31 | E1a_E1e (S0) | 13.50 | 1997.54% | RPS16 | E3b_E4a (S0) | 13.82 | 34.37% |
| 200 | PABPC1 | E14a_E15a (S0) | 13.49 | 43.08% | TPT1 | E1a_E1e (S0) | 13.82 | 20.85% |
| 201 | APOC1 | E2a_E3a (S0) | 13.48 | 299.16% | GAPDH | E5a_E6a (S0) | 13.81 | 35.95% |
| 202 | RPS8 | E4a_E5a (S0) | 13.48 | 32.30% | EEF2 | E7a_E8a (S0) | 13.81 | 52.31% |
| 203 | RPL4 | E3a_E4a (S0) | 13.48 | 27.14% | RPL5 | E3a_E4a (S0) | 13.80 | 29.01% |
| 204 | GAPDH | E9a_E10a (S0) | 13.47 | 31.73% | EEF2 | E5a_E6a (S0) | 13.79 | 51.82% |
| 205 | RPLP2 | E2a_E3a (S0) | 13.47 | 26.00% | TMSB4X | E1a_E1d (S0) | 13.78 | 35.41% |
| 206 | EEF1A1 | E4b_E5a (S0) | 13.44 | 34.55% | RPS3 | E3a_E4a (S0) | 13.77 | 21.43% |
| 207 | CD37 | E2a_E3a (S0) | 13.43 | 78.71% | RPL26 | E3a_E4a (S0) | 13.74 | 16.14% |
| 208 | EEF2 | E14a_E15a (S0) | 13.43 | 34.39% | PTMA | E2a_E4a (S3) | 13.73 | 121.06% |
| 209 | EEF1G | E5a_E6a (S0) | 13.42 | 36.43% | RPS5 | E4a_E5a (S0) | 13.72 | 36.29% |
| 210 | NPM1 | E2a_E3a (S0) | 13.42 | 144.50% | AF235103.4 | E5a_E6a (S0) | 13.72 | 41.91% |
| 211 | RPL13 | E3a_E4a (S0) | 13.41 | 50.32% | RPS10 | E4a_E5a (S0) | 13.72 | 21.72% |
| 212 | VIM | E2a_E3a (S0) | 13.41 | 39.37% | RPS13 | E4a_E5a (S0) | 13.71 | 22.66% |
| 213 | LAPTM5 | E6a_E7a (S0) | 13.40 | 43.27% | RPS7 | E3a_E4a (S0) | 13.70 | 54.11% |
| 214 | EEF2 | E3a_E4a (S0) | 13.40 | 33.71% | PABPC1 | E6a_E7a (S0) | 13.70 | 55.68% |
| 215 | TMSB4X | E1d_E2a (S0) | 13.40 | 34.07% | HLA-B | E13a_E14b (S0) | 13.70 | 44.64% |
| 216 | RPL5 | E4a_E5a (S0) | 13.39 | 42.86% | RPS2 | E4a_E5a (S0) | 13.70 | 32.41% |
| 217 | CFL1 | E3a_E4a (S0) | 13.38 | 42.03% | RPL14 | E5a_E6a (S0) | 13.69 | 86.24% |
| 218 | TMSB10 | E1a_E2a (S0) | 13.38 | 32.55% | HLA-E | E7a_E8a (S0) | 13.69 | 93.54% |
| 219 | EEF1G | E9a_E10a (S0) | 13.37 | 35.24% | LAPTM5 | E2a_E3a (S0) | 13.67 | 79.80% |
| 220 | HLA-DPA1 | E4b_E5a (S0) | 13.36 | 43.75% | RPS5 | E3a_E4a (S0) | 13.67 | 35.04% |
| 221 | RPL5 | E3a_E4a (S0) | 13.36 | 41.82% | FAU | E4a_E5a (S0) | 13.66 | 44.08% |
| 222 | HLA-DPA1 | E3a_E4a (S0) | 13.35 | 43.43% | EEF1G | E8a_E9a (S0) | 13.65 | 40.88% |
| 223 | HSPA8 | E4a_E5a (S0) | 13.35 | 43.32% | RPL4 | E3a_E4a (S0) | 13.64 | 32.15% |
| 224 | RPL10A | E4a_E5a (S0) | 13.34 | 45.25% | RPS15A | E2a_E3a (S0) | 13.63 | 15.34% |
| 225 | IGFBP7 | E4a_E5a (S0) | 13.34 | 77.48% | C17orf45 | E4a_E5a (S0) | 13.62 | 91.86% |
| 226 | RPL6 | E3a_E4a (S0) | 13.33 | 29.91% | ARHGDIB | E2a_E3a (S0) | 13.62 | 66.46% |
| 227 | PTGDS | E3a_E4a (S0) | 13.33 | 79.88% | RPL18 | E5a_E6a (S0) | 13.62 | 32.79% |
| 228 | RPS23 | E3a_E4a (S0) | 13.33 | 131.19% | RPL37A | E3a_E4a (S0) | 13.61 | 16.39% |
| 229 | ARHGDIB | E5a_E6a (S0) | 13.32 | 40.38% | EEF2 | E9a_E10a (S0) | 13.60 | 45.30% |
| 230 | EEF2 | E11a_E12a (S0) | 13.32 | 31.95% | PABPC1 | E5a_E6a (S0) | 13.59 | 51.36% |
| 231 | RPL15 | E3a_E4a (S0) | 13.32 | 90.95% | EEF1G | E3a_E4a (S0) | 13.58 | 38.94% |
| 232 | RPLP1 | E1a_E2a (S0) | 13.31 | 21.79% | RPL32 | E3a_E4a (S0) | 13.58 | 67.22% |
| 233 | PABPC1 | E10a_E11a (S0) | 13.31 | 37.91% | EEF1G | E9a_E10a (S0) | 13.57 | 38.80% |
| 234 | RPLP0 | E3a_E4a (S0) | 13.31 | 29.79% | IGHM | E4a_E5a (S0) | 13.57 | 15.29% |
| 235 | RPL10A | E5a_E6a (S0) | 13.30 | 44.01% | PABPC1 | E7a_E8a (S0) | 13.57 | 50.67% |
| 236 | RPL19 | E5a_E6a (S0) | 13.29 | 26.98% | EEF1G | E5a_E6a (S0) | 13.56 | 38.42% |
| 237 | EEF2 | E12a_E13a (S0) | 13.28 | 31.05% | RPS13 | E3a_E4a (S0) | 13.56 | 20.43% |
| 238 | RPS14 | E2a_E3a (S0) | 13.28 | 74.28% | RPL35 | E2a_E3a (S0) | 13.55 | 25.61% |
| 239 | EEF1G | E10a_E11a (S0) | 13.27 | 32.74% | RPL4 | E7a_E8a (S0) | 13.55 | 30.37% |
| 240 | ATP5E | E2a_E2b (S0) | 13.27 | 551.75% | RPL37A | E2a_E3a (S0) | 13.55 | 15.64% |
| 241 | RPL13A | E5a_E6a (S0) | 13.27 | 37.35% | EEF2 | E6a_E7a (S0) | 13.54 | 43.58% |
| 242 | EEF2 | E13a_E14a (S0) | 13.27 | 30.75% | HLA-B | E3a_E4a (S0) | 13.54 | 39.99% |
| 243 | TIMP1 | E5b_E6a (S0) | 13.26 | 92.57% | RPL23 | E4a_E5a (S0) | 13.53 | 34.81% |
| 244 | HSP90AB1 | E3a_E4a (S0) | 13.26 | 102.46% | RPS15 | E3a_E4a (S0) | 13.52 | 25.15% |
| 245 | C17orf45 | E4a_E5a (S0) | 13.26 | 168.23% | PABPC1 | E9b_E10a (S0) | 13.51 | 48.81% |
| 246 | C3 | E37a_E38a (S0) | 13.26 | 51.67% | PFDN5 | E3a_E4a (S0) | 13.50 | 82.09% |
| 247 | RPL36 | E3a_E4a (S0) | 13.25 | 68.72% | PABPC1 | E3a_E4a (S0) | 13.49 | 48.12% |
| 248 | CD74 | E1a_E2a (S0) | 13.25 | 4.59% | EEF2 | E4a_E5a (S0) | 13.46 | 41.25% |
| 249 | RPS18 | E4a_E5a (S0) | 13.25 | 16.25% | AF235103.4 | E6a_E7a (S0) | 13.46 | 34.92% |
| 250 | TMSB4X | E1a_E1d (S0) | 13.24 | 30.66% | AC100778.5 | E3a_E4a (S0) | 13.45 | 198.12% |
| 251 | RPL22 | E3a_E4a (S0) | 13.23 | 145.60% | RPL13 | E4a_E5a (S0) | 13.44 | 40.34% |
| 252 | EIF3E | E2a_E3a (S0) | 13.23 | 119.67% | RPL10A | E3a_E4a (S0) | 13.43 | 30.53% |
| 253 | C3 | E36a_E37a (S0) | 13.23 | 50.65% | APOC1 | E2a_E3a (S0) | 13.43 | 273.48% |
| 254 | C3 | E31a_E32a (S0) | 13.23 | 50.55% | PABPC1 | E4a_E5a (S0) | 13.42 | 45.80% |
| 255 | LAPTM5 | E3a_E4a (S0) | 13.22 | 38.13% | PABPC1 | E8a_E9a (S0) | 13.42 | 45.76% |
| 256 | HSPA8 | E8a_E9a (S0) | 13.22 | 39.53% | EEF2 | E10a_E11a (S0) | 13.41 | 39.72% |
| 257 | UBC | E2c_E2k (S0) | 13.21 | 61.16% | PABPC1 | E2a_E3a (S0) | 13.40 | 45.25% |
| 258 | C3 | E33a_E34a (S0) | 13.21 | 50.12% | NACA | E5a_E6a (S0) | 13.39 | 66.46% |
| 259 | MS4A1 | E3a_E4a (S0) | 13.21 | 44.95% | RPS5 | E5a_E6a (S0) | 13.36 | 28.28% |
| 260 | B2M | E1a_E2a (S0) | 13.20 | 7.64% | OAZ1 | E1a_E2a (S0) | 13.36 | 85.85% |
| 261 | TMBIM6 | E3a_E4a (S0) | 13.20 | 88.94% | UCP2 | E7a_E8a (S0) | 13.36 | 56.70% |
| 262 | RPS5 | E4a_E5a (S0) | 13.20 | 44.69% | HLA-DRB1 | E4a_E5a (S0) | 13.36 | 86.98% |
| 263 | GLTSCR2 | E1a_E2a (S0) | 13.19 | 151.10% | ARHGDIB | E1a_E2a (S0) | 13.35 | 55.32% |
| 264 | SH3BGRL3 | E3a_E3b (S0) | 13.18 | 100.78% | GLTSCR2 | E1a_E2a (S0) | 13.34 | 204.54% |
| 265 | PTGDS | E4a_E5a (S0) | 13.18 | 71.85% | PABPC1 | E10a_E11a (S0) | 13.32 | 42.69% |
| 266 | RPL4 | E7a_E8a (S0) | 13.17 | 21.99% | HLA-E | E3a_E4a (S0) | 13.30 | 71.43% |
| 267 | HLA-E | E5a_E6b (S0) | 13.17 | 48.02% | RPL6 | E2a_E3a (S0) | 13.30 | 22.73% |
| 268 | C3 | E32a_E33a (S0) | 13.17 | 48.53% | HSPA8 | E4a_E5a (S0) | 13.30 | 41.39% |
| 269 | VIM | E1a_E2a (S0) | 13.16 | 33.29% | PABPC1 | E14a_E15a (S0) | 13.28 | 41.67% |
| 270 | HSPA8 | E7b_E8a (S0) | 13.16 | 37.99% | HSPA8 | E8a_E9a (S0) | 13.28 | 41.05% |
| 271 | CD74 | E6a_E7a (S0) | 13.15 | 4.30% | RPL15 | E2a_E3a (S0) | 13.28 | 67.28% |
| 272 | C3 | E35a_E36a (S0) | 13.15 | 47.96% | HSPA8 | E6a_E7a (S0) | 13.27 | 40.74% |
| 273 | MYL6 | E3a_E4a (S0) | 13.14 | 61.95% | PTMA | E6a_E7a (S0) | 13.27 | 88.21% |
| 274 | LAPTM5 | E7a_E8a (S0) | 13.14 | 36.13% | CD79B | E5a_E6a (S0) | 13.27 | 53.43% |
| 275 | CXCL13 | E3a_E4a (S0) | 13.14 | 104.93% | EIF4A1 | E3a_E4c (S0) | 13.27 | 505.76% |
| 276 | C3 | E38a_E39a (S0) | 13.13 | 47.25% | TMSB10 | E2a_E3a (S0) | 13.26 | 17.80% |
| 277 | MS4A1 | E2a_E3a (S0) | 13.12 | 42.29% | CFL1 | E2a_E3a (S0) | 13.26 | 52.47% |
| 278 | RPS6 | E2c_E2f (S0) | 13.12 | 31.42% | RPL11 | E2a_E3a (S0) | 13.26 | 14.82% |
| 279 | CORO1A | E7a_E8a (S0) | 13.12 | 53.18% | UCP2 | E5a_E6a (S0) | 13.26 | 52.73% |
| 280 | MS4A1 | E5a_E6a (S0) | 13.11 | 42.01% | RPL13A | E7a_E8a (S0) | 13.25 | 18.68% |
| 281 | CD79A | E4a_E5a (S0) | 13.11 | 45.15% | EEF1G | E4a_E5a (S0) | 13.24 | 30.70% |
| 282 | RHOA | E3a_E4a (S0) | 13.10 | 56.92% | HSPA8 | E7b_E8a (S0) | 13.24 | 39.71% |
| 283 | RPL5 | E7a_E8a (S0) | 13.10 | 34.89% | NDUFA4 | E2a_E3a (S0) | 13.24 | 96.42% |
| 284 | CD79A | E3a_E4a (S0) | 13.09 | 44.58% | LAPTM5 | E4a_E5a (S0) | 13.23 | 58.73% |
| 285 | HSPA8 | E6a_E7a (S0) | 13.09 | 36.23% | NME1-NME2 | E10c_E11a (S0) | 13.23 | 251.81% |
| 286 | EEF2 | E2a_E3a (S0) | 13.09 | 27.22% | HLA-DPB1 | E8a_E9a (S0) | 13.23 | 78.40% |
| 287 | ARHGDIB | E4a_E5a (S0) | 13.09 | 34.32% | EEF2 | E11a_E12a (S0) | 13.22 | 34.74% |
| 288 | FTH1 | E2a_E3a (S0) | 13.09 | 57.53% | DDX5 | E1a_E2a (S0) | 13.20 | 52.42% |
| 289 | TUBB | E1a_E3a (S3) | 13.08 | 87.44% | CORO1A | E5a_E6a (S0) | 13.20 | 63.94% |
| 290 | AF235103.4 | E5a_E6a (S0) | 13.07 | 38.87% | RPL38 | E3a_E4a (S0) | 13.18 | 20.96% |
| 291 | VIL2 | E5a_E6a (S0) | 13.06 | 96.49% | MYL6 | E5a_E7a (S2) | 13.18 | 38.38% |
| 292 | IGHM | E4a_E5a (S0) | 13.05 | 13.73% | EEF1G | E10a_E11a (S0) | 13.18 | 29.48% |
| 293 | RPS9 | E3a_E4a (S0) | 13.04 | 90.48% | RPL5 | E6a_E7a (S0) | 13.17 | 18.78% |
| 294 | LUM | E1a_E2a (S0) | 13.04 | 97.68% | RPL39 | E2a_E3a (S0) | 13.17 | 9.50% |
| 295 | EIF1 | E3a_E4a (S0) | 13.03 | 92.14% | RPS15A | E4a_E5a (S0) | 13.17 | 11.15% |
| 296 | RPS11 | E2a_E3a (S0) | 13.03 | 14.32% | UCP2 | E6a_E7a (S0) | 13.16 | 49.32% |
| 297 | IGHA1 | E1a_E2a (S0) | 13.03 | 73.81% | CRIP1 | E3a_E4a (S0) | 13.15 | 241.39% |
| 298 | EIF4G2 | E1a_E2a (S0) | 13.02 | 79.65% | RPL34 | E4a_E5a (S0) | 13.14 | 20.16% |
| 299 | RPL13A | E7a_E8a (S0) | 13.01 | 31.37% | RPL30 | E7a_E8a (S0) | 13.13 | 14.99% |
| 300 | RPL14 | E5a_E6a (S0) | 13.01 | 72.75% | ARHGDIB | E5a_E6a (S0) | 13.13 | 47.26% |
| 301 | RPS19 | E3a_E4a (S0) | 13.01 | 43.78% | PABPC1 | E12a_E13a (S0) | 13.13 | 37.34% |
| 302 | PSAP | E10a_E11a (S0) | 12.99 | 53.59% | TUBB | E1a_E3a (S3) | 13.12 | 124.14% |
| 303 | C3 | E18a_E19a (S0) | 12.97 | 42.39% | HLA-DPA1 | E3a_E4a (S0) | 13.11 | 51.92% |
| 304 | PTMA | E2a_E4a (S3) | 12.97 | 76.66% | RPL13 | E3a_E4a (S0) | 13.11 | 32.10% |
| 305 | RPS3 | E3a_E4a (S0) | 12.96 | 27.36% | RPS5 | E2a_E3a (S0) | 13.11 | 23.70% |
| 306 | RPS16 | E2a_E3a (S0) | 12.96 | 37.02% | EEF2 | E3a_E4a (S0) | 13.11 | 32.25% |
| 307 | LCP1 | E8a_E9a (S0) | 12.96 | 44.88% | BTF3 | E2a_E3a (S0) | 13.10 | 81.59% |
| 308 | RPS10 | E2a_E3a (S0) | 12.96 | 30.60% | FTL | E3a_E4a (S0) | 13.10 | 40.59% |
| 309 | PSAP | E13a_E14a (S0) | 12.95 | 52.15% | RPL38 | E1a_E2a (S0) | 13.09 | 19.70% |
| 310 | C3 | E19a_E20a (S0) | 12.95 | 41.68% | RPL12 | E4a_E5a (S0) | 13.08 | 26.76% |
| 311 | HNRNPK | E4a_E5a (S0) | 12.94 | 139.77% | MYL6 | E4a_E5a (S0) | 13.08 | 35.91% |
| 312 | RPS3 | E5a_E6a (S0) | 12.93 | 26.89% | ARHGDIB | E4a_E5a (S0) | 13.07 | 45.27% |
| 313 | IGFBP7 | E3a_E4a (S0) | 12.93 | 58.42% | BTF3 | E5a_E6a (S0) | 13.06 | 79.50% |
| 314 | HLA-DPB1 | E6b_E8a (S1) | 12.93 | 54.30% | RPS25 | E4a_E5a (S0) | 13.06 | 10.59% |
| 315 | RPS11 | E4a_E5a (S0) | 12.93 | 13.33% | EEF2 | E12a_E13a (S0) | 13.05 | 30.89% |
| 316 | CORO1A | E9a_E10a (S0) | 12.92 | 46.43% | RPL5 | E1a_E2a (S0) | 13.04 | 17.09% |
| 317 | RPS2 | E4a_E5a (S0) | 12.91 | 21.50% | PFN1 | E1a_E2a (S0) | 13.03 | 27.98% |
| 318 | GAPDH | E8a_E9a (S0) | 12.91 | 21.53% | RPL35 | E3a_E5a (S1) | 13.03 | 17.78% |
| 319 | RPS3 | E2a_E3a (S0) | 12.89 | 26.09% | EEF2 | E13a_E14a (S0) | 13.03 | 30.46% |
| 320 | PABPC1 | E11a_E12a (S0) | 12.89 | 28.36% | HLA-DPA1 | E5a_E6a (S0) | 13.02 | 48.74% |
| 321 | NACA | E5a_E6a (S0) | 12.89 | 64.64% | NACA | E3a_E4a (S0) | 13.02 | 51.15% |
| 322 | HCLS1 | E3a_E4a (S0) | 12.89 | 123.37% | EEF2 | E14a_E15a (S0) | 13.02 | 30.25% |
| 323 | C3 | E1a_E2a (S0) | 12.89 | 39.97% | RPS19 | E4a_E5a (S0) | 13.01 | 25.37% |
| 324 | RPS16 | E3a_E3b (S0) | 12.88 | 34.92% | TTLL3 | E1a_E2a (S0) | 13.00 | 644.46% |
| 325 | C3 | E28a_E29a (S0) | 12.87 | 39.61% | HSPA8 | E5a_E6a (S0) | 12.99 | 33.53% |
| 326 | C3 | E39a_E40a (S0) | 12.87 | 39.47% | RPL24 | E4a_E5a (S0) | 12.99 | 19.74% |
| 327 | EIF4B | E1a_E2a (S0) | 12.86 | 150.30% | DDX5 | E8a_E9a (S0) | 12.99 | 45.17% |
| 328 | ARPC3 | E4a_E5a (S0) | 12.86 | 64.22% | LAPTM5 | E7a_E8a (S0) | 12.98 | 49.37% |
| 329 | HSPA8 | E5a_E6a (S0) | 12.86 | 30.91% | CD79B | E3a_E4a (S0) | 12.96 | 43.24% |
| 330 | PTPRC | E2a_E3a (S0) | 12.86 | 91.93% | PFDN5 | E2a_E3a (S0) | 12.96 | 56.26% |
| 331 | C3 | E26a_E27a (S0) | 12.86 | 39.21% | SLC25A6 | E1a_E2a (S0) | 12.96 | 71.63% |
| 332 | C3 | E27a_E28a (S0) | 12.86 | 39.17% | RPL6 | E3a_E4a (S0) | 12.95 | 17.91% |
| 333 | CALM2 | E4a_E5a (S0) | 12.86 | 108.19% | HSPA8 | E3a_E4a (S0) | 12.95 | 32.47% |
| 334 | ACTB | E1a_E2a (S0) | 12.85 | 3.48% | CD37 | E7a_E8a (S0) | 12.94 | 43.70% |
| 335 | C3 | E9a_E10a (S0) | 12.84 | 38.82% | CFL1 | E3a_E4a (S0) | 12.94 | 42.07% |
| 336 | SPARC | E6a_E7a (S0) | 12.83 | 77.38% | AC069236.27 | E5a_E6a (S0) | 12.93 | 128.48% |
| 337 | RPS14 | E4a_E5a (S0) | 12.83 | 54.32% | FAU | E5a_E6a (S0) | 12.93 | 26.60% |
| 338 | TIMP1 | E5a_E5b (S0) | 12.82 | 68.18% | RPS19 | E5a_E6a (S0) | 12.93 | 24.15% |
| 339 | RPS5 | E3a_E4a (S0) | 12.82 | 34.41% | PABPC1 | E13a_E14a (S0) | 12.91 | 32.21% |
| 340 | PABPC1 | E13a_E14a (S0) | 12.82 | 27.03% | EIF4B | E1a_E2a (S0) | 12.91 | 180.94% |
| 341 | RPS20 | E3a_E4a (S0) | 12.81 | 21.00% | PABPC1 | E11a_E12a (S0) | 12.91 | 32.11% |
| 342 | AF235103.4 | E6a_E7a (S0) | 12.80 | 32.29% | LAPTM5 | E5a_E6a (S0) | 12.90 | 46.61% |
| 343 | C3 | E21a_E22a (S0) | 12.80 | 37.72% | EIF4A1 | E5a_E6a (S0) | 12.90 | 390.91% |
| 344 | LCP1 | E16a_E17a (S0) | 12.80 | 40.35% | RPL27A | E3a_E4a (S0) | 12.89 | 224.76% |
| 345 | C3 | E34a_E35a (S0) | 12.80 | 37.68% | NACA | E6a_E7a (S0) | 12.89 | 46.96% |
| 346 | RPS3 | E4a_E5a (S0) | 12.80 | 24.51% | HLA-A | E10a_E11a (S0) | 12.88 | 72.24% |
| 347 | HLA-E | E4a_E5a (S0) | 12.80 | 37.01% | CD79A | E4a_E5a (S0) | 12.88 | 42.15% |
| 348 | IGHE | E1a_E2a (S0) | 12.80 | 69.11% | GAPDH | E8a_E9a (S0) | 12.87 | 18.84% |
| 349 | LCP1 | E11a_E12a (S0) | 12.79 | 39.93% | IGHE | E2b_E3a (S0) | 12.86 | 59.39% |
| 350 | NAP1L1 | E6a_E7a (S0) | 12.78 | 128.20% | VIM | E6a_E7a (S0) | 12.86 | 69.60% |
| 351 | CAPZA1 | E5a_E6a (S0) | 12.78 | 175.89% | RPS12 | E5a_E6a (S0) | 12.85 | 13.42% |
| 352 | PTMA | E6a_E7a (S0) | 12.77 | 66.65% | C4orf7 | E1a_E2a (S0) | 12.84 | 46.61% |
| 353 | CTSB | E3a_E4a (S0) | 12.77 | 109.28% | UBA52 | E3a_E4a (S0) | 12.83 | 27.92% |
| 354 | RPS2 | E2a_E3a (S0) | 12.77 | 19.40% | EIF3E | E5a_E6a (S0) | 12.83 | 53.79% |
| 355 | RPL12 | E2a_E3a (S0) | 12.76 | 33.44% | UCP2 | E4a_E5a (S0) | 12.82 | 39.05% |
| 356 | C3 | E30a_E31a (S0) | 12.76 | 36.65% | CD79B | E4a_E5a (S0) | 12.82 | 39.23% |
| 357 | CORO1A | E5a_E6a (S0) | 12.76 | 41.55% | FTL | E2a_E3a (S0) | 12.82 | 33.41% |
| 358 | HLA-A | E10a_E11a (S0) | 12.75 | 56.78% | RPL11 | E5a_E6a (S0) | 12.82 | 10.91% |
| 359 | EEF1G | E3a_E4a (S0) | 12.75 | 22.94% | RPLP2 | E4a_E5a (S0) | 12.81 | 12.25% |
| 360 | IGFBP7 | E2a_E3a (S0) | 12.75 | 51.72% | SSR2 | E1a_E2a (S0) | 12.81 | 826.78% |
| 361 | LCP1 | E10a_E11a (S0) | 12.75 | 38.89% | CD79A | E3a_E4a (S0) | 12.81 | 40.13% |
| 362 | LCP1 | E9a_E10a (S0) | 12.74 | 38.74% | IGHE | E1a_E2a (S0) | 12.81 | 57.05% |
| 363 | C3 | E20a_E21a (S0) | 12.74 | 36.03% | CD37 | E6a_E7a (S0) | 12.81 | 39.82% |
| 364 | RPL5 | E6a_E7a (S0) | 12.73 | 27.09% | RPL32 | E2a_E3a (S0) | 12.81 | 39.38% |
| 365 | CD74 | E7a_E8a (S0) | 12.73 | 3.20% | DDX5 | E4a_E5a (S0) | 12.80 | 39.63% |
| 366 | IGFBP7 | E1a_E2a (S0) | 12.73 | 50.83% | NPM1 | E7a_E8a (S0) | 12.80 | 80.17% |
| 367 | GSTP1 | E1a_E2a (S0) | 12.72 | 166.93% | CORO1A | E9a_E10a (S0) | 12.80 | 48.25% |
| 368 | LCP1 | E14a_E15a (S0) | 12.71 | 37.94% | DDX5 | E7a_E8a (S0) | 12.79 | 39.44% |
| 369 | TOMM7 | E3a_E5a (S1) | 12.71 | 135.51% | HLA-E | E6a_E7a (S0) | 12.79 | 50.20% |
| 370 | RPL27 | E3a_E4a (S0) | 12.70 | 19.03% | CD37 | E4a_E6a (S1) | 12.78 | 39.13% |
| 371 | TPT1 | E1a_E1e (S0) | 12.70 | 16.99% | CD74 | E1a_E2a (S0) | 12.78 | 4.76% |
| 372 | LCP1 | E7a_E8a (S0) | 12.70 | 37.52% | PTPRC | E2a_E3a (S0) | 12.77 | 89.92% |
| 373 | C3 | E22a_E23a (S0) | 12.70 | 35.06% | RPL35A | E4a_E5a (S0) | 12.76 | 11.71% |
| 374 | AP005329.1 | E2a_E3a (S0) | 12.68 | 71.08% | NAP1L1 | E6a_E7a (S0) | 12.76 | 124.28% |
| 375 | PSAP | E6a_E7a (S0) | 12.68 | 43.26% | RPS24 | E3a_E4a (S0) | 12.75 | 28.45% |
| 376 | RPS13 | E5a_E6a (S0) | 12.68 | 24.17% | RPL21 | E3a_E4a (S0) | 12.73 | 18.15% |
| 377 | RPL18A | E4a_E5a (S0) | 12.67 | 85.38% | SH3BGRL3 | E3a_E3b (S0) | 12.73 | 91.91% |
| 378 | RPS23 | E2a_E3a (S0) | 12.67 | 83.25% | DDX5 | E10a_E11a (S0) | 12.73 | 37.64% |
| 379 | RPS16 | E3b_E4a (S0) | 12.67 | 30.21% | HLA-E | E5a_E6b (S0) | 12.73 | 47.95% |
| 380 | OAZ1 | E1a_E2a (S0) | 12.66 | 59.13% | HLA-DPA1 | E4b_E5a (S0) | 12.72 | 39.58% |
| 381 | COMMD6 | E5a_E7a (S1) | 12.66 | 527.57% | UBL5 | E3a_E4a (S0) | 12.72 | 128.11% |
| 382 | RPS18 | E5a_E6a (S0) | 12.65 | 10.75% | UCP2 | E3a_E4a (S0) | 12.71 | 36.07% |
| 383 | LCP1 | E18a_E19a (S0) | 12.65 | 36.30% | RPSA | E2a_E3a (S0) | 12.70 | 70.70% |
| 384 | LCP1 | E13a_E14a (S0) | 12.65 | 36.29% | CD37 | E3a_E4a (S0) | 12.69 | 36.81% |
| 385 | SPARC | E8a_E9a (S0) | 12.65 | 68.22% | RPL30 | E4a_E6a (S1) | 12.69 | 11.04% |
| 386 | BTF3 | E4a_E5a (S0) | 12.64 | 76.08% | RPL27 | E4a_E5a (S0) | 12.69 | 10.16% |
| 387 | PSAP | E12a_E13a (S0) | 12.64 | 42.21% | UBC | E2c_E2k (S0) | 12.68 | 56.04% |
| 388 | APOC1 | E4a_E5a (S0) | 12.64 | 166.99% | IGHV4-31 | E1a_E2a (S0) | 12.68 | 44.41% |
| 389 | HSPA8 | E3a_E4a (S0) | 12.64 | 26.57% | HLA-B | E5a_E6a (S0) | 12.68 | 22.00% |
| 390 | LCP1 | E15a_E16a (S0) | 12.64 | 35.96% | BTF3 | E4a_E5a (S0) | 12.67 | 60.54% |
| 391 | TTLL3 | E1a_E2a (S0) | 12.63 | 646.34% | HNRNPK | E4a_E5a (S0) | 12.67 | 151.06% |
| 392 | ITM2B | E3a_E4a (S0) | 12.63 | 67.71% | RHOA | E3a_E4a (S0) | 12.67 | 59.34% |
| 393 | RHOA | E4a_E5a (S0) | 12.62 | 40.83% | HLA-DPB1 | E6b_E8a (S1) | 12.66 | 53.06% |
| 394 | HLA-B | E5a_E6a (S0) | 12.62 | 20.61% | ARPC3 | E5a_E6a (S0) | 12.66 | 46.57% |
| 395 | PTPRC | E29a_E30a (S0) | 12.62 | 77.76% | OAZ1 | E4a_E5a (S0) | 12.66 | 52.72% |
| 396 | LCP1 | E17a_E18a (S0) | 12.61 | 35.23% | LAPTM5 | E6a_E7a (S0) | 12.64 | 38.95% |
| 397 | IRF8 | E2a_E3a (S0) | 12.60 | 89.25% | OAZ1 | E3a_E4a (S0) | 12.63 | 51.69% |
| 398 | IGJ | E2a_E3a (S0) | 12.60 | 62.83% | VIM | E4a_E5a (S0) | 12.62 | 58.99% |
| 399 | ACTG1 | E1a_E2a (S0) | 12.60 | 7.98% | RPL36 | E3a_E4a (S0) | 12.62 | 21.37% |
| 400 | RPL11 | E2a_E3a (S0) | 12.59 | 14.04% | ARPC3 | E6a_E7a (S0) | 12.62 | 45.24% |
| 401 | PSAP | E9a_E10a (S0) | 12.59 | 40.62% | SLC25A6 | E3a_E4a (S0) | 12.61 | 56.48% |
| 402 | RPL35A | E2a_E3a (S0) | 12.59 | 15.48% | NPM1 | E2a_E3a (S0) | 12.61 | 70.62% |
| 403 | PSAP | E7a_E9b (S1) | 12.59 | 40.56% | EIF3E | E10a_E11a (S0) | 12.61 | 46.24% |
| 404 | FTL | E1a_E2a (S0) | 12.59 | 14.35% | HLA-DPB1 | E4a_E6a (S1) | 12.60 | 50.80% |
| 405 | PABPC1 | E1a_E2a (S0) | 12.58 | 22.96% | PTPRC | E29a_E30a (S0) | 12.60 | 79.76% |
| 406 | SSR2 | E1a_E2a (S0) | 12.58 | 781.24% | RPL23 | E5a_E6a (S0) | 12.59 | 18.23% |
| 407 | CORO1A | E4a_E5a (S0) | 12.57 | 36.49% | ARPC2 | E6a_E7a (S0) | 12.57 | 66.10% |
| 408 | PTGDS | E2a_E3a (S0) | 12.57 | 47.07% | HLA-B | E15a_E16a (S0) | 12.56 | 20.31% |
| 409 | RPL11 | E5a_E6a (S0) | 12.57 | 13.77% | PABPC1 | E1a_E2a (S0) | 12.56 | 25.25% |
| 410 | LCP1 | E6a_E7a (S0) | 12.56 | 34.21% | NACA | E4a_E5a (S0) | 12.56 | 37.29% |
| 411 | PKM2 | E7a_E8a (S0) | 12.56 | 69.09% | RPL10 | E2b_E4a (S1) | 12.55 | 33.73% |
| 412 | ANXA2 | E1a_E3a (S1) | 12.56 | 140.03% | RPS3 | E6b_E7a (S0) | 12.55 | 9.22% |
| 413 | UCP2 | E7a_E8a (S0) | 12.56 | 60.56% | RPL13A | E8a_E9a (S0) | 12.55 | 11.50% |
| 414 | C3 | E8a_E9a (S0) | 12.55 | 31.75% | GSTP1 | E1a_E2a (S0) | 12.55 | 164.16% |
| 415 | RPL5 | E1a_E2a (S0) | 12.55 | 23.93% | HLA-E | E4a_E5a (S0) | 12.55 | 42.32% |
| 416 | C3 | E5a_E6a (S0) | 12.55 | 31.71% | NDUFB3 | E1a_E2a (S0) | 12.54 | 205.24% |
| 417 | SELL | E7a_E8a (S0) | 12.55 | 67.05% | ATP6V0E | E2a_E3a (S0) | 12.54 | 103.21% |
| 418 | VIL2 | E10a_E11a (S0) | 12.55 | 67.55% | RPS7 | E5a_E6a (S0) | 12.53 | 24.05% |
| 419 | PSAP | E14a_E15a (S0) | 12.55 | 39.45% | HIGD1A | E1a_E2a (S0) | 12.53 | 203.95% |
| 420 | CD79B | E4a_E5a (S0) | 12.55 | 46.73% | DDX5 | E5a_E6a (S0) | 12.53 | 32.79% |
| 421 | HLA-B | E15a_E16a (S0) | 12.54 | 19.53% | RPS9 | E3a_E4a (S0) | 12.52 | 48.13% |
| 422 | ARPC3 | E5a_E6a (S0) | 12.54 | 51.43% | EEF2 | E2a_E3a (S0) | 12.52 | 21.47% |
| 423 | RPS29 | E2a_E3a (S0) | 12.54 | 60.39% | RPLP0 | E2a_E3a (S0) | 12.51 | 9.76% |
| 424 | PSAP | E2a_E3a (S0) | 12.54 | 39.24% | DDX5 | E3a_E4a (S0) | 12.49 | 32.00% |
| 425 | CORO1A | E3a_E4a (S0) | 12.54 | 35.60% | CDC42 | E2a_E4a (S1) | 12.49 | 214.77% |
| 426 | CDC42 | E2a_E4a (S1) | 12.53 | 216.75% | EIF3E | E2a_E3a (S0) | 12.49 | 42.53% |
| 427 | NAP1L1 | E3a_E4a (S0) | 12.53 | 107.82% | ARPC3 | E4a_E5a (S0) | 12.49 | 41.33% |
| 428 | CORO1A | E8a_E9a (S0) | 12.53 | 35.48% | RPS21 | E3a_E3b (S0) | 12.49 | 39.98% |
| 429 | RPS27 | E3a_E3b (S0) | 12.53 | 13.94% | CORO1A | E7a_E8a (S0) | 12.48 | 38.86% |
| 430 | HLA-DPB1 | E4a_E6a (S1) | 12.53 | 41.28% | RPS27A | E2b_E3a (S0) | 12.48 | 15.04% |
| 431 | PKM2 | E2b_E3a (S0) | 12.53 | 67.39% | ARPC3 | E7a_E8a (S0) | 12.48 | 40.97% |
| 432 | ITM2B | E4a_E5a (S0) | 12.53 | 63.07% | PTPRC | E6a_E7a (S0) | 12.48 | 73.40% |
| 433 | SEPT9 | E10a_E11a (S0) | 12.51 | 142.19% | SNRPD2 | E3a_E4a (S0) | 12.47 | 105.26% |
| 434 | HLA-B | E11a_E12a (S0) | 12.51 | 19.12% | PRDX1 | E1a_E2a (S0) | 12.47 | 132.29% |
| 435 | LCP1 | E12a_E13a (S0) | 12.50 | 32.70% | ATP2A3 | E17a_E18a (S0) | 12.47 | 57.20% |
| 436 | RPS5 | E5a_E6a (S0) | 12.50 | 27.51% | HSPA8 | E1a_E2a (S0) | 12.46 | 23.16% |
| 437 | EIF4A2 | E3a_E4a (S0) | 12.49 | 109.38% | BTF3 | E3a_E4a (S0) | 12.46 | 52.23% |
| 438 | C4orf34 | E2a_E3a (S0) | 12.49 | 133.33% | CORO1A | E4a_E5a (S0) | 12.46 | 38.14% |
| 439 | S100A11 | E2a_E3a (S0) | 12.49 | 88.80% | LAPTM5 | E3a_E4a (S0) | 12.46 | 34.30% |
| 440 | SPARC | E7a_E8a (S0) | 12.49 | 61.02% | RAN | E1a_E2b (S0) | 12.45 | 140.37% |
| 441 | RPS27A | E5a_E6a (S0) | 12.48 | 37.17% | UXT | E2a_E2b (S0) | 12.45 | 212.35% |
| 442 | CYBA | E3a_E4a (S0) | 12.48 | 77.06% | OAZ1 | E5a_E6a (S0) | 12.45 | 45.48% |
| 443 | RAC2 | E6a_E7a (S0) | 12.47 | 57.78% | APOE | E1a_E2a (S0) | 12.45 | 161.83% |
| 444 | GNAI2 | E7a_E8a (S0) | 12.47 | 55.03% | ARPC2 | E7a_E8a (S0) | 12.43 | 60.17% |
| 445 | C3 | E29a_E30a (S0) | 12.47 | 29.85% | HLA-B | E11a_E12a (S0) | 12.43 | 18.49% |
| 446 | C3 | E25a_E26a (S0) | 12.46 | 29.80% | IGHV4-31 | E2a_E3a (S0) | 12.43 | 37.22% |
| 447 | RPL4 | E4a_E5a (S0) | 12.46 | 13.41% | C11orf10 | E1a_E2a (S0) | 12.43 | 155.97% |
| 448 | HLA-DQA1 | E2a_E3a (S0) | 12.46 | 107.94% | COTL1 | E3a_E4a (S0) | 12.43 | 72.13% |
| 449 | HSPA8 | E1a_E2a (S0) | 12.46 | 23.37% | AC069236.27 | E7b_E8a (S0) | 12.42 | 90.13% |
| 450 | CD37 | E4a_E6a (S1) | 12.45 | 39.85% | AF235103.4 | E4a_E5a (S0) | 12.42 | 16.99% |
| 451 | ARPC2 | E6a_E7a (S0) | 12.44 | 63.17% | EIF1 | E3a_E4a (S0) | 12.41 | 60.95% |
| 452 | SRP14 | E3a_E4a (S0) | 12.44 | 77.06% | COMMD6 | E5a_E7a (S1) | 12.41 | 239.93% |
| 453 | RPL18 | E5a_E6a (S0) | 12.44 | 21.88% | AF235103.4 | E3a_E4a (S0) | 12.41 | 16.80% |
| 454 | EIF4A1 | E5a_E6a (S0) | 12.44 | 245.22% | EIF1 | E2a_E3a (S0) | 12.40 | 60.51% |
| 455 | CTSZ | E3a_E4a (S0) | 12.44 | 112.58% | EIF3E | E8a_E9a (S0) | 12.40 | 39.99% |
| 456 | ARHGDIB | E3a_E4a (S0) | 12.43 | 21.76% | VIM | E7a_E8a (S0) | 12.40 | 50.67% |
| 457 | PSAP | E5a_E6a (S0) | 12.43 | 36.42% | PTPRC | E4a_E6a (S2) | 12.40 | 69.49% |
| 458 | ARPC2 | E9a_E10a (S0) | 12.43 | 62.48% | VIL2 | E5a_E6a (S0) | 12.38 | 88.28% |
| 459 | RPL18 | E4a_E5a (S0) | 12.43 | 21.62% | GTF2A2 | E3a_E4a (S0) | 12.37 | 453.05% |
| 460 | C3 | E6a_E7a (S0) | 12.42 | 29.02% | VIM | E8a_E9a (S0) | 12.37 | 49.73% |
| 461 | PSAP | E4b_E5a (S0) | 12.42 | 36.20% | RPL23A | E5a_E6a (S0) | 12.37 | 189.65% |
| 462 | CD79B | E5a_E6a (S0) | 12.42 | 42.75% | RAC2 | E6a_E7a (S0) | 12.37 | 62.09% |
| 463 | CORO1A | E6a_E7a (S0) | 12.42 | 32.78% | FTL | E1a_E2a (S0) | 12.36 | 24.33% |
| 464 | RPL26 | E3a_E4a (S0) | 12.42 | 9.47% | RPS10 | E5a_E7a (S2) | 12.36 | 8.48% |
| 465 | COTL1 | E3a_E4a (S0) | 12.41 | 61.86% | AP005329.1 | E3a_E4a (S0) | 12.35 | 65.91% |
| 466 | EIF4G2 | E16a_E17a (S0) | 12.41 | 52.16% | SLC25A3 | E1b_E3a (S1) | 12.35 | 97.27% |
| 467 | NACA | E6a_E7a (S0) | 12.41 | 46.36% | RPL28 | E1a_E2a (S0) | 12.35 | 1326.23% |
| 468 | TAGLN2 | E4a_E5a (S0) | 12.41 | 88.39% | IGJ | E3a_E4a (S0) | 12.34 | 34.42% |
| 469 | GABARAP | E2a_E3a (S0) | 12.40 | 56.85% | PTPRC | E3a_E4a (S0) | 12.34 | 66.87% |
| 470 | HLA-A | E9a_E10a (S0) | 12.40 | 44.54% | NAP1L1 | E5a_E6a (S0) | 12.34 | 92.80% |
| 471 | AP005329.1 | E3a_E4a (S0) | 12.40 | 58.44% | ACTB | E1a_E2a (S0) | 12.34 | 3.83% |
| 472 | SYNGR2 | E2a_E3a (S0) | 12.40 | 60.61% | CTSS | E2a_E3a (S0) | 12.34 | 226.52% |
| 473 | EIF1 | E2a_E3a (S0) | 12.40 | 59.35% | DDX5 | E6a_E7a (S0) | 12.34 | 28.70% |
| 474 | NACA | E4a_E5a (S0) | 12.40 | 46.09% | CD79B | E2a_E3a (S0) | 12.33 | 27.99% |
| 475 | RPL10A | E3a_E4a (S0) | 12.40 | 23.55% | HNRNPA1 | E2a_E3a (S0) | 12.33 | 79.47% |
| 476 | C3 | E23a_E24a (S0) | 12.40 | 28.44% | RPS27A | E3a_E4a (S0) | 12.33 | 13.52% |
| 477 | GNAI2 | E8a_E9a (S0) | 12.40 | 52.33% | ATP2A3 | E19a_E20a (S0) | 12.32 | 51.79% |
| 478 | C3 | E24a_E25a (S0) | 12.40 | 28.43% | RPL10 | E4a_E5a (S0) | 12.31 | 28.56% |
| 479 | PSAP | E11a_E12a (S0) | 12.40 | 35.53% | IGHV4-31 | E3a_E4a (S0) | 12.31 | 34.39% |
| 480 | CD37 | E6a_E7a (S0) | 12.39 | 38.23% | CLIC1 | E4b_E5a (S0) | 12.31 | 135.58% |
| 481 | GNAI2 | E6a_E7a (S0) | 12.39 | 52.10% | PTPRC | E33a_E34a (S0) | 12.31 | 65.30% |
| 482 | ARPC1B | E3a_E4a (S0) | 12.39 | 90.38% | NACA | E7a_E8a (S0) | 12.31 | 31.29% |
| 483 | RPL27A | E4a_E5a (S0) | 12.39 | 369.06% | CORO1A | E8a_E9a (S0) | 12.29 | 34.08% |
| 484 | OAZ1 | E3a_E4a (S0) | 12.38 | 48.77% | CORO1A | E6a_E7a (S0) | 12.29 | 33.99% |
| 485 | RAN | E1a_E2b (S0) | 12.38 | 177.46% | RPS9 | E4a_E5b (S0) | 12.29 | 40.88% |
| 486 | C3 | E7a_E8a (S0) | 12.38 | 28.16% | ATP2A3 | E18a_E19a (S0) | 12.29 | 50.44% |
| 487 | VIL2 | E9a_E10a (S0) | 12.38 | 60.04% | PHB2 | E7a_E8a (S0) | 12.28 | 83.32% |
| 488 | PRDX1 | E1a_E2a (S0) | 12.37 | 101.21% | NPM1 | E8a_E9a (S0) | 12.28 | 56.09% |
| 489 | OAZ1 | E5a_E6a (S0) | 12.37 | 48.31% | CCL21 | E3a_E3b (S0) | 12.28 | 47.43% |
| 490 | PTPRC | E33a_E34a (S0) | 12.37 | 65.33% | GNB2L1 | E7a_E8a (S0) | 12.27 | 9.57% |
| 491 | ITM2B | E5a_E6a (S0) | 12.36 | 56.19% | EIF3E | E9a_E10a (S0) | 12.27 | 36.46% |
| 492 | RPS18 | E2a_E3a (S0) | 12.36 | 8.75% | PTPRC | E7a_E8a (S0) | 12.27 | 63.45% |
| 493 | CST3 | E3a_E4a (S0) | 12.36 | 158.41% | TCEB2 | E1a_E2b (S0) | 12.26 | 303.56% |
| 494 | ACTR2 | E2a_E5a (S2) | 12.35 | 84.99% | HLA-DMB | E1a_E2a (S0) | 12.26 | 55.52% |
| 495 | PTGDS | E5a_E6a (S0) | 12.35 | 40.32% | RGS13 | E5a_E6a (S0) | 12.26 | 44.92% |
| 496 | EIF4G2 | E18a_E19a (S0) | 12.34 | 49.83% | NAP1L1 | E7a_E8a (S0) | 12.25 | 87.41% |
| 497 | OAZ1 | E4a_E5a (S0) | 12.34 | 47.25% | ARHGDIB | E3a_E4a (S0) | 12.25 | 25.73% |
| 498 | RPL28 | E1a_E2a (S0) | 12.34 | 1174.61% | CORO1A | E3a_E4a (S0) | 12.25 | 33.07% |
| 499 | C3 | E17a_E18a (S0) | 12.34 | 27.29% | LCP1 | E8a_E9a (S0) | 12.25 | 42.81% |
| 500 | EIF4G2 | E6a_E7a (S0) | 12.34 | 49.58% | ARPC2 | E5a_E6a (S0) | 12.25 | 52.88% |
| 501 | CD79B | E3a_E4a (S0) | 12.34 | 40.39% | NME1-NME2 | E12a_E13a (S0) | 12.24 | 127.04% |
| 502 | C3 | E40a_E41a (S0) | 12.34 | 27.29% | EIF3E | E4a_E5a (S0) | 12.24 | 35.83% |
| 503 | TMBIM6 | E7a_E8a (S0) | 12.33 | 48.83% | ATP5O | E3a_E4a (S0) | 12.24 | 108.06% |
| 504 | NAP1L1 | E5a_E6a (S0) | 12.33 | 93.82% | SPIB | E2a_E3a (S0) | 12.24 | 117.10% |
| 505 | IGHE | E2b_E3a (S0) | 12.32 | 49.82% | RPL13A | E4a_E5a (S0) | 12.24 | 9.28% |
| 506 | SEPP1 | E3a_E4a (S0) | 12.32 | 82.79% | RPL9 | E3a_E4a (S0) | 12.24 | 90.64% |
| 507 | NPM1 | E7a_E8a (S0) | 12.32 | 67.17% | SLC25A3 | E5a_E6a (S0) | 12.23 | 89.96% |
| 508 | RPS14 | E3a_E4a (S0) | 12.32 | 38.12% | HNRNPA1 | E9a_E10a (S0) | 12.23 | 73.95% |
| 509 | UBD | E1a_E2a (S0) | 12.32 | 236.32% | NAP1L1 | E8a_E9a (S0) | 12.23 | 85.90% |
| 510 | FTH1 | E1b_E2a (S0) | 12.31 | 33.57% | LCP1 | E9a_E10a (S0) | 12.21 | 41.78% |
| 511 | PSAP | E3a_E4a (S0) | 12.31 | 33.44% | SLC25A6 | E2a_E3a (S0) | 12.21 | 42.80% |
| 512 | HNRNPK | E10a_E11a (S0) | 12.31 | 90.03% | CD74 | E6a_E7a (S0) | 12.21 | 3.20% |
| 513 | PFDN5 | E3a_E4a (S0) | 12.31 | 73.54% | PFDN5 | E4a_E5a (S0) | 12.19 | 33.07% |
| 514 | RPL30 | E7a_E8a (S0) | 12.30 | 11.29% | ATP2A3 | E16a_E17a (S0) | 12.18 | 47.05% |
| 515 | FTH1 | E3a_E4a (S0) | 12.30 | 33.41% | ARPC2 | E9a_E10a (S0) | 12.18 | 50.67% |
| 516 | RPL12 | E3a_E4a (S0) | 12.30 | 24.26% | PTPRC | E32b_E33a (S0) | 12.18 | 59.81% |
| 517 | C3 | E4a_E5a (S0) | 12.30 | 26.54% | RPL29 | E3a_E4a (S0) | 12.18 | 9.77% |
| 518 | HLA-DPA1 | E2a_E3a (S0) | 12.30 | 20.88% | EIF3E | E6a_E7a (S0) | 12.17 | 34.11% |
| 519 | YWHAZ | E8a_E9a (S0) | 12.29 | 63.78% | ATP2A3 | E14a_E15a (S0) | 12.17 | 46.63% |
| 520 | NAP1L1 | E7a_E8a (S0) | 12.29 | 91.08% | RPS7 | E4a_E5a (S0) | 12.17 | 18.68% |
| 521 | DYNLL1 | E3a_E4a (S0) | 12.29 | 160.84% | ENO1 | E2a_E3a (S0) | 12.17 | 57.36% |
| 522 | PTPRC | E25a_E26a (S0) | 12.28 | 61.71% | RPL19 | E2a_E3a (S0) | 12.16 | 8.91% |
| 523 | MYL6 | E4a_E5a (S0) | 12.28 | 34.21% | RPLP0 | E1a_E2a (S0) | 12.15 | 7.60% |
| 524 | C3 | E10a_E11a (S0) | 12.28 | 26.23% | EWSR1 | E1a_E2a (S0) | 12.15 | 177.97% |
| 525 | PTPRC | E18a_E19a (S0) | 12.28 | 61.40% | LCP1 | E11a_E12a (S0) | 12.15 | 39.95% |
| 526 | ARPC2 | E7a_E8a (S0) | 12.27 | 56.14% | RHOA | E4a_E5a (S0) | 12.14 | 41.09% |
| 527 | RPS10 | E4a_E5a (S0) | 12.27 | 19.05% | DAZAP2 | E2a_E3a (S0) | 12.13 | 74.60% |
| 528 | TMSB10 | E2a_E3a (S0) | 12.27 | 15.06% | ATP2A3 | E7a_E8a (S0) | 12.13 | 45.43% |
| 529 | HLA-DMB | E1a_E2a (S0) | 12.27 | 62.64% | RAC2 | E7b_E8a (S0) | 12.13 | 52.59% |
| 530 | RAC2 | E7b_E8a (S0) | 12.26 | 50.07% | SLC25A3 | E6a_E7a (S0) | 12.13 | 83.55% |
| 531 | RPL32 | E2a_E3a (S0) | 12.26 | 44.90% | ARPC2 | E8a_E9a (S0) | 12.12 | 48.56% |
| 532 | HNRPA2B1 | E4a_E5a (S0) | 12.26 | 89.73% | CD48 | E2a_E3a (S0) | 12.12 | 96.48% |
| 533 | PTPRC | E21a_E22a (S0) | 12.26 | 60.56% | PCBP2 | E13a_E14a (S0) | 12.12 | 55.87% |
| 534 | ENO1 | E8a_E9a (S0) | 12.26 | 46.92% | PTPRC | E34a_E35a (S0) | 12.11 | 57.09% |
| 535 | SPARC | E4a_E5a (S0) | 12.26 | 52.03% | ATPIF1 | E2a_E4a (S1) | 12.11 | 122.86% |
| 536 | HSP90AB1 | E6a_E7a (S0) | 12.25 | 51.00% | HLA-DQA1 | E2a_E3a (S0) | 12.11 | 126.74% |
| 537 | COL1A1 | E50a_E51a (S0) | 12.25 | 79.07% | CD53 | E2a_E3a (S0) | 12.11 | 52.96% |
| 538 | ARPC3 | E7a_E8a (S0) | 12.24 | 41.83% | PKM2 | E7a_E8a (S0) | 12.11 | 60.94% |
| 539 | ENO1 | E5a_E6a (S0) | 12.24 | 46.45% | CALM2 | E6a_E7a (S0) | 12.11 | 44.01% |
| 540 | DDX5 | E8a_E9a (S0) | 12.24 | 47.00% | DDX5 | E2a_E3a (S0) | 12.10 | 24.47% |
| 541 | PTPRC | E22a_E23a (S0) | 12.24 | 59.83% | RPL38 | E4a_E5a (S0) | 12.10 | 9.92% |
| 542 | RPL32 | E3a_E4a (S0) | 12.24 | 44.21% | CD74 | E7a_E8a (S0) | 12.10 | 2.98% |
| 543 | AL645929.4 | E5a_E6a (S0) | 12.24 | 638.84% | PTPRC | E25a_E26a (S0) | 12.10 | 56.56% |
| 544 | C3 | E3a_E4a (S0) | 12.23 | 25.43% | CD44 | E5a_E6a (S0) | 12.10 | 152.01% |
| 545 | PKM2 | E5a_E6a (S0) | 12.23 | 54.70% | RPS3A | E5a_E6a (S0) | 12.10 | 13.99% |
| 546 | RPL10 | E2b_E4a (S1) | 12.23 | 30.96% | EIF3E | E7a_E8a (S0) | 12.10 | 32.37% |
| 547 | PTPRC | E7a_E8a (S0) | 12.22 | 59.21% | RPS24 | E4a_E7a (S2) | 12.09 | 18.11% |
| 548 | FCER2 | E8a_E9a (S0) | 12.22 | 49.37% | LCP1 | E17a_E18a (S0) | 12.09 | 38.47% |
| 549 | HNRNPA1 | E9a_E10a (S0) | 12.22 | 72.18% | VIM | E3a_E4a (S0) | 12.09 | 40.85% |
| 550 | RPL39 | E2a_E3a (S0) | 12.22 | 9.87% | CD79A | E2a_E3a (S0) | 12.08 | 24.30% |
| 551 | TAGLN2 | E1a_E4a (S2) | 12.22 | 77.47% | SRP14 | E3a_E4a (S0) | 12.08 | 50.59% |
| 552 | C3 | E11a_E12a (S0) | 12.21 | 25.08% | PTPRC | E16a_E17a (S0) | 12.08 | 55.91% |
| 553 | UCP2 | E5a_E6a (S0) | 12.21 | 47.66% | LCP1 | E18a_E19a (S0) | 12.08 | 38.11% |
| 554 | NAP1L1 | E8a_E9a (S0) | 12.21 | 86.21% | ANXA2 | E13a_E14a (S0) | 12.08 | 149.94% |
| 555 | VIL2 | E7a_E8a (S0) | 12.21 | 53.33% | LCP1 | E15a_E16a (S0) | 12.08 | 38.10% |
| 556 | CTSC | E1a_E2a (S0) | 12.21 | 71.11% | AP005329.2 | E5a_E6a (S0) | 12.08 | 77.66% |
| 557 | PTPRC | E17a_E18a (S0) | 12.20 | 58.39% | SYNGR2 | E2a_E3a (S0) | 12.08 | 55.15% |
| 558 | RPLP2 | E4a_E5a (S0) | 12.20 | 10.85% | VIM | E5a_E6a (S0) | 12.07 | 40.38% |
| 559 | SERPING1 | E2a_E3b (S0) | 12.20 | 141.24% | RPL27 | E2a_E3a (S0) | 12.07 | 6.61% |
| 560 | PTPRC | E23a_E24a (S0) | 12.20 | 58.30% | PTPRC | E27a_E28a (S0) | 12.07 | 55.38% |
| 561 | HMGN2 | E4a_E5a (S0) | 12.20 | 66.05% | DDX5 | E9a_E10a (S0) | 12.07 | 23.86% |
| 562 | TUBB | E4a_E5a (S0) | 12.20 | 47.56% | ATP2A3 | E10a_E11a (S0) | 12.07 | 43.32% |
| 563 | SLC25A6 | E3a_E4a (S0) | 12.20 | 44.80% | YBX1 | E3a_E4a (S0) | 12.07 | 78.13% |
| 564 | ARPC2 | E5a_E6a (S0) | 12.20 | 53.31% | LCP1 | E7a_E8a (S0) | 12.06 | 37.66% |
| 565 | TPM3 | E8a_E10a (S1) | 12.20 | 317.76% | LCP1 | E10a_E11a (S0) | 12.06 | 37.58% |
| 566 | PTPRC | E34a_E35a (S0) | 12.20 | 58.18% | LCP1 | E13a_E14a (S0) | 12.05 | 37.36% |
| 567 | CCNI | E4a_E5a (S0) | 12.20 | 51.50% | ARPC3 | E3a_E4a (S0) | 12.05 | 30.43% |
| 568 | XRCC6 | E1a_E2e (S0) | 12.20 | 131.73% | RPL34 | E2a_E3a (S0) | 12.04 | 9.37% |
| 569 | HNRPA2B1 | E11a_E12a (S0) | 12.20 | 86.04% | NAP1L1 | E11a_E12a (S0) | 12.03 | 74.96% |
| 570 | RPL27A | E3a_E4a (S0) | 12.19 | 322.93% | PTPRC | E17a_E18a (S0) | 12.03 | 53.87% |
| 571 | RPS19 | E5a_E6a (S0) | 12.19 | 24.83% | GNAI2 | E7a_E8a (S0) | 12.03 | 53.04% |
| 572 | CD81 | E8a_E9a (S0) | 12.19 | 74.98% | C17orf45 | E3a_E4a (S0) | 12.02 | 30.28% |
| 573 | EIF3E | E5a_E6a (S0) | 12.19 | 58.22% | EIF3F | E6a_E7a (S0) | 12.02 | 214.96% |
| 574 | ARHGDIA | E1a_E2a (S0) | 12.19 | 174.35% | HLA-DRB1 | E3a_E4a (S0) | 12.02 | 34.41% |
| 575 | EEF1D | E5a_E6a (S0) | 12.18 | 127.65% | RGS13 | E6a_E7a (S0) | 12.02 | 38.17% |
| 576 | CD37 | E7a_E8a (S0) | 12.18 | 33.01% | PCBP2 | E4a_E5a (S0) | 12.02 | 52.18% |
| 577 | TRDV2 | E2a_E3a (S0) | 12.18 | 42.63% | RGS13 | E2a_E3a (S0) | 12.01 | 38.02% |
| 578 | CTSB | E10a_E11a (S0) | 12.18 | 72.71% | UCP2 | E2a_E3a (S0) | 12.01 | 22.30% |
| 579 | HLA-B | E12a_E13a (S0) | 12.18 | 15.13% | VIM | E2a_E3a (S0) | 12.01 | 38.58% |
| 580 | RPS3A | E2a_E3a (S0) | 12.17 | 27.78% | BTG2 | E1a_E2a (S0) | 12.01 | 118.05% |
| 581 | HSP90AA1 | E4a_E5a (S0) | 12.17 | 70.70% | PTPRC | E26a_E27a (S0) | 12.00 | 52.88% |
| 582 | C4orf7 | E4a_E5a (S0) | 12.17 | 17.97% | ARPC2 | E3a_E4a (S0) | 12.00 | 44.57% |
| 583 | GRN | E1a_E2a (S0) | 12.17 | 96.24% | C20orf30 | E4a_E5a (S0) | 12.00 | 214.87% |
| 584 | PKM2 | E6a_E7a (S0) | 12.17 | 52.50% | ARPC5 | E1a_E2b (S0) | 12.00 | 56.44% |
| 585 | CORO1A | E2a_E3a (S0) | 12.17 | 27.57% | GNAI2 | E6a_E7a (S0) | 12.00 | 51.96% |
| 586 | RPS13 | E3a_E4a (S0) | 12.17 | 16.96% | PCBP2 | E3a_E4a (S0) | 11.99 | 51.34% |
| 587 | UQCR | E2a_E3a (S0) | 12.16 | 471.68% | HLA-DMA | E5a_E6a (S0) | 11.99 | 52.09% |
| 588 | PTPRC | E32b_E33a (S0) | 12.16 | 56.63% | NAP1L1 | E9a_E10a (S0) | 11.99 | 72.86% |
| 589 | CD79A | E2a_E3a (S0) | 12.16 | 23.35% | SSR4 | E3a_E4a (S0) | 11.99 | 292.17% |
| 590 | EIF4G2 | E11a_E12a (S0) | 12.15 | 43.57% | ATP2A3 | E15a_E16a (S0) | 11.99 | 41.03% |
| 591 | SEPT9 | E8a_E9a (S0) | 12.15 | 110.47% | ALOX5AP | E2a_E3a (S0) | 11.99 | 85.05% |
| 592 | SEPT9 | E4a_E5a (S0) | 12.15 | 110.45% | RAC2 | E2a_E4a (S1) | 11.98 | 47.56% |
| 593 | RPL30 | E4a_E6a (S1) | 12.15 | 10.12% | SEPT9 | E10a_E11a (S0) | 11.98 | 145.35% |
| 594 | PTPRC | E28a_E29a (S0) | 12.14 | 56.00% | ENO1 | E8a_E9a (S0) | 11.98 | 50.46% |
| 595 | HLA-DMA | E5a_E6a (S0) | 12.14 | 59.34% | PTPRC | E35a_E36a (S0) | 11.98 | 51.92% |
| 596 | YBX1 | E3a_E4a (S0) | 12.14 | 68.93% | HNRNPA1 | E10a_E11a (S0) | 11.98 | 61.96% |
| 597 | YWHAZ | E7a_E8a (S0) | 12.14 | 57.19% | EIF3EIP | E5a_E6a (S0) | 11.97 | 67.93% |
| 598 | RPL38 | E1a_E2a (S0) | 12.14 | 18.20% | PFDN5 | E5a_E6a (S0) | 11.97 | 28.45% |
| 599 | COL1A1 | E47a_E48a (S0) | 12.14 | 72.98% | COX7 | E1a_E2a (S0) | 11.97 | 27.04% |
| 600 | PTPRC | E16a_E17a (S0) | 12.13 | 55.50% | STAG3 | E33a_E34a (S0) | 11.97 | 718.06% |
| 601 | RPS15 | E3a_E4a (S0) | 12.13 | 14.99% | EIF3K | E2a_E3a (S0) | 11.97 | 88.94% |
| 602 | YWHAZ | E10a_E11a (S0) | 12.13 | 56.76% | EIF3E | E3a_E4a (S0) | 11.96 | 29.53% |
| 603 | CD81 | E9a_E10a (S0) | 12.13 | 71.63% | FTH1 | E1b_E2a (S0) | 11.96 | 51.24% |
| 604 | CNN2 | E2a_E3a (S0) | 12.13 | 83.77% | APOC1 | E4a_E5a (S0) | 11.96 | 98.69% |
| 605 | PPP1CA | E2a_E3a (S0) | 12.13 | 82.34% | PTPRC | E30a_E32a (S1) | 11.96 | 51.38% |
| 606 | RPS9 | E4a_E5b (S0) | 12.12 | 47.76% | LCP1 | E14a_E15a (S0) | 11.96 | 35.01% |
| 607 | ANXA2 | E11a_E12a (S0) | 12.12 | 103.32% | TUBB | E4a_E5a (S0) | 11.96 | 55.49% |
| 608 | RHOA | E2a_E3a (S0) | 12.12 | 28.82% | CALM2 | E4a_E5a (S0) | 11.96 | 39.74% |
| 609 | HNRPA2B1 | E5a_E6a (S0) | 12.12 | 81.60% | RPL12 | E3a_E4a (S0) | 11.95 | 12.23% |
| 610 | HSPA8 | E2a_E3a (S0) | 12.12 | 18.50% | RPL4 | E4a_E5a (S0) | 11.95 | 10.00% |
| 611 | SEPP1 | E2a_E3a (S0) | 12.12 | 72.28% | RPLP1 | E3a_E4a (S0) | 11.95 | 5.11% |
| 612 | FCER2 | E7a_E8a (S0) | 12.12 | 45.92% | RPL5 | E2a_E3a (S0) | 11.95 | 8.04% |
| 613 | RPL38 | E2a_E3a (S0) | 12.12 | 17.96% | NPM1 | E3a_E4a (S0) | 11.95 | 44.57% |
| 614 | EIF4G2 | E15a_E16a (S0) | 12.11 | 42.44% | C4orf34 | E4a_E5a (S0) | 11.94 | 61.90% |
| 615 | POU2AF1 | E3a_E4a (S0) | 12.11 | 106.17% | SLC25A3 | E4a_E5a (S0) | 11.94 | 73.37% |
| 616 | PTPRC | E6a_E7a (S0) | 12.11 | 54.66% | GDI2 | E3a_E5a (S2) | 11.94 | 65.33% |
| 617 | YBX1 | E7c_E8a (S0) | 12.11 | 67.60% | NAP1L1 | E12a_E13a (S0) | 11.94 | 70.24% |
| 618 | ACTR3 | E2a_E3a (S0) | 12.11 | 54.06% | CYBA | E3a_E4a (S0) | 11.94 | 51.37% |
| 619 | HNRNPK | E6a_E7b (S0) | 12.11 | 78.40% | EIF3D | E3a_E4a (S0) | 11.94 | 119.95% |
| 620 | RPL12 | E4a_E5a (S0) | 12.11 | 21.20% | ACTR3 | E7a_E8a (S0) | 11.94 | 56.37% |
| 621 | SEPT9 | E5a_E6a (S0) | 12.10 | 107.02% | YWHAZ | E10a_E11a (S0) | 11.94 | 65.44% |
| 622 | YBX1 | E6b_E7a (S0) | 12.10 | 67.22% | ATP5J | E3a_E4a (S0) | 11.93 | 263.57% |
| 623 | UCP2 | E6a_E7a (S0) | 12.10 | 44.07% | CALM2 | E5a_E6a (S0) | 11.93 | 38.98% |
| 624 | C3 | E14a_E15a (S0) | 12.10 | 23.14% | EIF3F | E5a_E6a (S0) | 11.93 | 201.13% |
| 625 | CLIC1 | E4b_E5a (S0) | 12.09 | 113.01% | PTPRC | E21a_E22a (S0) | 11.93 | 50.19% |
| 626 | SEPT9 | E6a_E7a (S0) | 12.09 | 105.97% | PTPRC | E23a_E24a (S0) | 11.92 | 50.09% |
| 627 | BTF3 | E5a_E6a (S0) | 12.09 | 51.72% | NPM1 | E5a_E6a (S0) | 11.92 | 43.72% |
| 628 | ACTR3 | E7a_E8a (S0) | 12.09 | 53.35% | EIF3E | E11a_E12a (S0) | 11.92 | 28.66% |
| 629 | CXCL13 | E4a_E5a (S0) | 12.08 | 50.47% | VIL2 | E10a_E11a (S0) | 11.92 | 64.06% |
| 630 | NPM1 | E8a_E9a (S0) | 12.08 | 57.13% | CALM1 | E4a_E5a (S0) | 11.91 | 193.65% |
| 631 | EIF3EIP | E5a_E6a (S0) | 12.08 | 67.42% | UBD | E1a_E2a (S0) | 11.91 | 253.64% |
| 632 | RPS12 | E4a_E5a (S0) | 12.08 | 17.24% | TAGLN2 | E1a_E4a (S2) | 11.91 | 75.03% |
| 633 | CTSB | E7a_E8a (S0) | 12.08 | 67.72% | LCP1 | E12a_E13a (S0) | 11.91 | 33.83% |
| 634 | RPS5 | E2a_E3a (S0) | 12.08 | 20.53% | DYNLL1 | E3a_E4a (S0) | 11.91 | 73.55% |
| 635 | ALDOA | E14a_E15a (S0) | 12.08 | 81.09% | HLA-B | E12a_E13a (S0) | 11.90 | 12.85% |
| 636 | ENO1 | E10a_E11a (S0) | 12.08 | 41.38% | MRPS21 | E1a_E2b (S0) | 11.90 | 821.89% |
| 637 | GNAI2 | E5a_E6a (S0) | 12.07 | 41.85% | SLC25A5 | E3a_E4a (S0) | 11.90 | 49.13% |
| 638 | TRDV2 | E1a_E2a (S0) | 12.07 | 39.61% | PTPRC | E22a_E23a (S0) | 11.90 | 49.21% |
| 639 | HLA-DRB1 | E3a_E4a (S0) | 12.07 | 25.65% | LDHB | E3a_E4a (S0) | 11.89 | 81.23% |
| 640 | ITM2B | E2a_E3a (S0) | 12.07 | 45.93% | PTGDS | E3a_E4a (S0) | 11.89 | 86.34% |
| 641 | VIL2 | E8a_E9a (S0) | 12.07 | 48.44% | PTPRC | E19a_E20a (S0) | 11.89 | 49.01% |
| 642 | CTSB | E8a_E9a (S0) | 12.07 | 67.45% | PTPRC | E28a_E29a (S0) | 11.89 | 49.01% |
| 643 | C3 | E12a_E13a (S0) | 12.07 | 22.65% | PCBP2 | E5a_E6a (S0) | 11.89 | 47.85% |
| 644 | HNRNPK | E8a_E9a (S0) | 12.06 | 76.19% | XRCC6 | E1a_E2e (S0) | 11.89 | 143.47% |
| 645 | SLC25A6 | E2a_E3a (S0) | 12.06 | 40.66% | EIF4G2 | E11a_E12a (S0) | 11.88 | 50.14% |
| 646 | CD37 | E3a_E4a (S0) | 12.06 | 30.34% | GNAI2 | E8a_E9a (S0) | 11.88 | 48.02% |
| 647 | EIF4G2 | E8a_E9a (S0) | 12.06 | 40.85% | RPL12 | E6a_E7a (S0) | 11.88 | 11.60% |
| 648 | PTPRC | E27a_E28a (S0) | 12.06 | 52.71% | HLA-DMB | E2a_E3a (S0) | 11.88 | 42.60% |
| 649 | EIF4G2 | E9a_E10a (S0) | 12.06 | 40.84% | HNRPA2B1 | E4a_E5a (S0) | 11.88 | 74.61% |
| 650 | NAP1L1 | E11a_E12a (S0) | 12.06 | 77.51% | IRF8 | E2a_E3a (S0) | 11.88 | 57.03% |
| 651 | CTSS | E2a_E3a (S0) | 12.06 | 150.40% | UQCRQ | E1a_E1d (S0) | 11.87 | 531.27% |
| 652 | DDX5 | E7a_E8a (S0) | 12.06 | 41.39% | SSR2 | E2a_E3a (S0) | 11.87 | 431.22% |
| 653 | PCBP2 | E6a_E7a (S0) | 12.06 | 55.90% | YWHAZ | E9a_E10a (S0) | 11.87 | 62.64% |
| 654 | PCBP2 | E13a_E14a (S0) | 12.06 | 55.88% | HNRPA2B1 | E5a_E6a (S0) | 11.87 | 74.29% |
| 655 | CCNI | E3a_E4a (S0) | 12.05 | 46.56% | LCP1 | E16a_E17a (S0) | 11.87 | 32.87% |
| 656 | SEPP1 | E1a_E2a (S0) | 12.05 | 68.92% | GLTSCR2 | E3a_E4a (S0) | 11.87 | 73.38% |
| 657 | C3 | E16a_E17a (S0) | 12.05 | 22.39% | PTPRC | E18a_E19a (S0) | 11.86 | 48.04% |
| 658 | PTPRC | E19a_E20a (S0) | 12.05 | 52.48% | ARPC2 | E4a_E5a (S0) | 11.86 | 40.48% |
| 659 | RPS25 | E4a_E5a (S0) | 12.05 | 5.95% | PTPRC | E24a_E25a (S0) | 11.86 | 47.92% |
| 660 | RPS15A | E2a_E3a (S0) | 12.05 | 12.80% | RPS25 | E2a_E3a (S0) | 11.86 | 4.61% |
| 661 | DCN | E9a_E10a (S0) | 12.05 | 67.92% | ACTR3 | E8a_E9a (S0) | 11.86 | 53.35% |
| 662 | CALR | E2a_E3a (S0) | 12.05 | 64.13% | GGA2 | E5a_E6a (S0) | 11.85 | 79.02% |
| 663 | PCBP2 | E4a_E5a (S0) | 12.05 | 55.56% | SF3B1 | E2a_E3a (S0) | 11.85 | 92.23% |
| 664 | ALDOA | E12a_E13a (S0) | 12.04 | 79.36% | EIF3H | E3a_E4a (S0) | 11.85 | 50.89% |
| 665 | C3 | E15a_E16a (S0) | 12.04 | 22.30% | VIM | E1a_E2a (S0) | 11.85 | 34.65% |
| 666 | TMBIM6 | E5a_E6a (S0) | 12.04 | 39.88% | SLC25A5 | E2a_E3a (S0) | 11.85 | 47.42% |
| 667 | D87017.2 | E1a_E2a (S0) | 12.04 | 6313.86% | NAP1L1 | E3a_E4a (S0) | 11.84 | 65.81% |
| 668 | CAPZB | E8a_E9a (S0) | 12.03 | 92.44% | LCP1 | E6a_E7a (S0) | 11.84 | 32.29% |
| 669 | EIF4G2 | E4a_E5a (S0) | 12.03 | 40.12% | PTPRC | E11a_E12a (S0) | 11.84 | 47.27% |
| 670 | DDX5 | E10a_E11a (S0) | 12.03 | 40.65% | NPM1 | E9a_E11a (S1) | 11.84 | 41.27% |
| 671 | RPL9 | E3a_E4a (S0) | 12.03 | 185.07% | ATP2A3 | E6a_E7a (S0) | 11.83 | 36.89% |
| 672 | EIF4G2 | E17a_E18a (S0) | 12.03 | 40.02% | EIF3EIP | E8a_E9a (S0) | 11.83 | 61.42% |
| 673 | CCL5 | E3a_E4a (S0) | 12.03 | 204.42% | RPS27L | E1b_E2a (S0) | 11.83 | 428.22% |
| 674 | PTPRC | E30a_E32a (S1) | 12.02 | 51.45% | PKM2 | E8a_E10a (S1) | 11.82 | 50.06% |
| 675 | ARPC3 | E6a_E7a (S0) | 12.02 | 35.82% | NAP1L1 | E4a_E5a (S0) | 11.82 | 64.77% |
| 676 | MSN | E3a_E4a (S0) | 12.02 | 41.29% | CCL21 | E2a_E3a (S0) | 11.82 | 34.62% |
| 677 | SEPT9 | E11a_E12a (S0) | 12.02 | 100.72% | RPS20 | E1a_E2a (S0) | 11.82 | 4.93% |
| 678 | ITM2B | E1a_E2a (S0) | 12.01 | 44.13% | COX4I1 | E3a_E4a (S0) | 11.82 | 36.60% |
| 679 | CCNI | E5a_E6a (S0) | 12.01 | 45.25% | ACTR3 | E11a_E12a (S0) | 11.82 | 51.90% |
| 680 | RPL37A | E2a_E3a (S0) | 12.01 | 9.33% | GABARAP | E2a_E3a (S0) | 11.82 | 56.31% |
| 681 | EIF4G2 | E12a_E13a (S0) | 12.01 | 39.55% | EIF4G2 | E14a_E15a (S0) | 11.81 | 47.82% |
| 682 | PTPRC | E35a_E36a (S0) | 12.01 | 51.03% | HLA-E | E2a_E3a (S0) | 11.81 | 25.43% |
| 683 | CTSB | E9a_E10a (S0) | 12.01 | 64.58% | ENO1 | E10a_E11a (S0) | 11.81 | 44.73% |
| 684 | SRGN | E2a_E3a (S0) | 12.01 | 47.24% | CALM1 | E2a_E3a (S0) | 11.81 | 180.14% |
| 685 | TMBIM6 | E8a_E9a (S0) | 12.01 | 38.92% | EIF4G2 | E6a_E7a (S0) | 11.80 | 47.48% |
| 686 | XRCC6 | E3a_E4a (S0) | 12.00 | 115.13% | RPL9 | E5a_E6a (S0) | 11.80 | 67.05% |
| 687 | FCER2 | E10a_E11a (S0) | 12.00 | 42.38% | YBX1 | E7c_E8a (S0) | 11.80 | 65.02% |
| 688 | RAC2 | E4a_E5a (S0) | 12.00 | 41.73% | HMGN2 | E4a_E5a (S0) | 11.80 | 36.96% |
| 689 | RPL23A | E5a_E6a (S0) | 12.00 | 196.47% | ACTR2 | E2a_E5a (S2) | 11.79 | 86.81% |
| 690 | HLA-B | E14a_E15a (S0) | 12.00 | 13.39% | GNAI2 | E5a_E6a (S0) | 11.79 | 45.05% |
| 691 | SNRPD2 | E3a_E4a (S0) | 12.00 | 167.12% | COX4I1 | E4a_E5a (S0) | 11.78 | 35.74% |
| 692 | CDC42 | E5a_E6a (S0) | 11.99 | 148.89% | GDI2 | E8b_E9a (S0) | 11.78 | 58.51% |
| 693 | HSP90AB1 | E8a_E9a (S0) | 11.99 | 42.54% | POMP | E3a_E4a (S0) | 11.78 | 251.50% |
| 694 | DCN | E5a_E6a (S0) | 11.99 | 65.38% | EIF4G2 | E15a_E16a (S0) | 11.78 | 46.68% |
| 695 | IL2RG | E5a_E6a (S0) | 11.99 | 47.11% | SEPT9 | E4a_E5a (S0) | 11.77 | 125.78% |
| 696 | PTPRC | E4a_E6a (S2) | 11.99 | 50.41% | SEPT9 | E5a_E6a (S0) | 11.77 | 125.76% |
| 697 | COL1A1 | E48a_E49a (S0) | 11.99 | 65.78% | RPS8 | E2a_E3a (S0) | 11.77 | 5.31% |
| 698 | NDUFA4 | E2a_E3a (S0) | 11.98 | 90.78% | ATP2A3 | E11a_E12a (S0) | 11.77 | 35.28% |
| 699 | ATP2A3 | E19a_E20a (S0) | 11.98 | 62.63% | CD37 | E8a_E9a (S0) | 11.77 | 19.40% |
| 700 | EIF4G2 | E7a_E8a (S0) | 11.98 | 38.67% | GAPDH | E2a_E4a (S1) | 11.77 | 8.74% |
| 701 | NAPSB | E2a_E3a (S0) | 11.97 | 91.78% | EIF3F | E3a_E4a (S0) | 11.77 | 179.92% |
| 702 | RPL38 | E3a_E4a (S0) | 11.97 | 16.26% | YBX1 | E6b_E7a (S0) | 11.77 | 63.49% |
| 703 | HLA-E | E2a_E3a (S0) | 11.97 | 20.85% | C2orf79 | E1a_E2a (S0) | 11.76 | 153.57% |
| 704 | RPL38 | E4a_E5a (S0) | 11.97 | 16.23% | RPL13 | E2a_E3a (S0) | 11.76 | 12.57% |
| 705 | ARF1 | E3a_E4a (S0) | 11.97 | 91.90% | STAT6 | E18a_E19a (S0) | 11.76 | 77.24% |
| 706 | LUM | E2a_E3a (S0) | 11.97 | 46.32% | ENO1 | E5a_E6a (S0) | 11.76 | 43.16% |
| 707 | NPM1 | E9a_E11a (S1) | 11.97 | 52.73% | HLA-DPA1 | E2a_E3a (S0) | 11.76 | 20.25% |
| 708 | ARHGDIA | E2a_E3a (S0) | 11.97 | 149.33% | PKM2 | E6a_E7a (S0) | 11.76 | 47.75% |
| 709 | MSN | E11a_E12a (S0) | 11.96 | 39.79% | C17orf61 | E3a_E4a (S0) | 11.76 | 129.01% |
| 710 | SPARC | E5a_E6a (S0) | 11.96 | 42.35% | HLA-B | E14a_E15a (S0) | 11.76 | 11.59% |
| 711 | LDHB | E3a_E4a (S0) | 11.96 | 92.01% | CLU | E7a_E8a (S0) | 11.76 | 49.33% |
| 712 | PTPRC | E26a_E27a (S0) | 11.96 | 49.16% | PTPRC | E20a_E21a (S0) | 11.75 | 44.48% |
| 713 | VIL2 | E11a_E12a (S0) | 11.95 | 44.67% | HMGA1 | E7b_E8a (S0) | 11.75 | 91.05% |
| 714 | STAG3 | E33a_E34a (S0) | 11.95 | 758.38% | AC008155.10 | E2a_E3a (S0) | 11.75 | 23312.31% |
| 715 | EIF4G2 | E13a_E14a (S0) | 11.95 | 38.03% | ATP2A3 | E13a_E14a (S0) | 11.75 | 34.78% |
| 716 | CTSB | E5a_E6a (S0) | 11.95 | 62.20% | ALDOA | E14a_E15a (S0) | 11.75 | 82.06% |
| 717 | SPARC | E9a_E10a (S0) | 11.95 | 42.16% | AP005329.1 | E2a_E3a (S0) | 11.75 | 43.41% |
| 718 | HNRPA2B1 | E7b_E8a (S0) | 11.95 | 72.64% | CD22 | E13a_E14a (S0) | 11.75 | 46.01% |
| 719 | ALDOA | E10a_E11a (S0) | 11.95 | 74.34% | RAC2 | E5a_E6a (S0) | 11.75 | 40.31% |
| 720 | PLEK | E6a_E7a (S0) | 11.95 | 61.94% | RPL23 | E3a_E4a (S0) | 11.75 | 10.13% |
| 721 | EIF4G2 | E19a_E20a (S0) | 11.94 | 37.80% | PCBP2 | E6a_E7a (S0) | 11.74 | 43.20% |
| 722 | MSN | E6a_E7a (S0) | 11.94 | 39.29% | ACTG1 | E1a_E2a (S0) | 11.74 | 6.14% |
| 723 | CTSD | E8a_E9a (S0) | 11.94 | 62.08% | RPS21 | E3e_E3f (S0) | 11.74 | 23.81% |
| 724 | GSTP1 | E4a_E5a (S0) | 11.94 | 97.09% | CALR | E5a_E6a (S0) | 11.74 | 64.21% |
| 725 | ARPC2 | E8a_E9a (S0) | 11.94 | 44.56% | CORO1A | E10a_E11a (S0) | 11.73 | 23.07% |
| 726 | CD44 | E5a_E6a (S0) | 11.94 | 125.34% | CD53 | E7a_E8a (S0) | 11.72 | 40.54% |
| 727 | TPM3 | E11a_E14b (S5) | 11.94 | 265.18% | EIF4G2 | E16a_E17a (S0) | 11.72 | 44.92% |
| 728 | YBX1 | E5d_E6a (S0) | 11.94 | 60.06% | LTB | E2a_E3a (S0) | 11.72 | 54.43% |
| 729 | CD53 | E7a_E8a (S0) | 11.94 | 41.62% | ACTR3 | E2a_E3a (S0) | 11.72 | 48.64% |
| 730 | ACTR3 | E4a_E5a (S0) | 11.93 | 47.81% | H3F3A | E4a_E5a (S0) | 11.72 | 1000.01% |
| 731 | C3 | E13a_E14a (S0) | 11.93 | 20.58% | TAPBP | E5a_E6a (S0) | 11.72 | 94.64% |
| 732 | HNRNPK | E11a_E12a (S0) | 11.93 | 69.32% | RGS13 | E4a_E5a (S0) | 11.71 | 30.85% |
| 733 | HNRNPA3 | E10a_E11a (S0) | 11.93 | 253.49% | CD22 | E11a_E12a (S0) | 11.71 | 44.97% |
| 734 | NACA | E7a_E8a (S0) | 11.92 | 33.09% | DDX5 | E11a_E12a (S0) | 11.71 | 18.60% |
| 735 | EIF4G2 | E14a_E15a (S0) | 11.92 | 37.15% | NME1-NME2 | E11a_E12a (S0) | 11.71 | 87.71% |
| 736 | RPL10 | E4a_E5a (S0) | 11.92 | 25.01% | CSTA | E2a_E3a (S0) | 11.70 | 271.91% |
| 737 | EWSR1 | E1a_E2a (S0) | 11.92 | 173.15% | EIF3H | E4a_E5a (S0) | 11.70 | 45.92% |
| 738 | CD81 | E6a_E7a (S0) | 11.92 | 61.98% | VIL2 | E9a_E10a (S0) | 11.70 | 55.07% |
| 739 | EIF3H | E3a_E4a (S0) | 11.92 | 57.59% | YWHAZ | E8a_E9a (S0) | 11.70 | 55.53% |
| 740 | PLA2G2A | E2a_E3a (S0) | 11.91 | 173.35% | EIF3EIP | E6a_E7a (S0) | 11.70 | 56.18% |
| 741 | TUBB | E3a_E4a (S0) | 11.91 | 38.95% | GDI2 | E7a_E8a (S0) | 11.70 | 55.31% |
| 742 | CD53 | E6a_E7a (S0) | 11.91 | 40.99% | RPS12 | E2a_E3a (S0) | 11.70 | 6.02% |
| 743 | ACTR3 | E11a_E12a (S0) | 11.91 | 47.20% | TAGLN2 | E5a_E6a (S0) | 11.70 | 64.74% |
| 744 | RPL23 | E5a_E6a (S0) | 11.91 | 13.68% | EIF1 | E1a_E2a (S0) | 11.70 | 37.08% |
| 745 | IGHA1 | E2a_E3a (S0) | 11.91 | 34.02% | VAMP8 | E2a_E4a (S1) | 11.69 | 120.11% |
| 746 | CAPZB | E10a_E11a (S0) | 11.91 | 84.72% | SASH3 | E1a_E2a (S0) | 11.69 | 49.72% |
| 747 | ENO1 | E9a_E10a (S0) | 11.91 | 36.82% | ATP2A3 | E9a_E10a (S0) | 11.69 | 33.43% |
| 748 | HNRNPC | E5a_E6a (S0) | 11.90 | 90.72% | SLC25A3 | E7a_E8a (S0) | 11.69 | 61.78% |
| 749 | EIF4G2 | E10a_E11a (S0) | 11.90 | 36.74% | HNRNPC | E5a_E6a (S0) | 11.69 | 88.70% |
| 750 | ARPC2 | E3a_E4a (S0) | 11.90 | 43.25% | GGA2 | E4a_E5a (S0) | 11.69 | 70.43% |
| 751 | PTPRC | E20a_E21a (S0) | 11.90 | 47.20% | COPE | E2a_E3a (S0) | 11.68 | 99.30% |
| 752 | PTGDS | E1a_E2a (S0) | 11.90 | 29.55% | ATP5A1 | E3a_E4a (S0) | 11.68 | 55.81% |
| 753 | GAPDH | E2a_E4a (S1) | 11.89 | 10.65% | PPP1CA | E2a_E3a (S0) | 11.68 | 56.16% |
| 754 | SELL | E6a_E7a (S0) | 11.89 | 42.49% | EIF3EIP | E9a_E10a (S0) | 11.68 | 55.34% |
| 755 | HSP90AB1 | E12a_E13a (S0) | 11.89 | 39.74% | EIF3EIP | E4a_E5a (S0) | 11.68 | 55.33% |
| 756 | DDX3X | E3a_E4a (S0) | 11.89 | 123.76% | LDHA | E2a_E3a (S0) | 11.68 | 78.08% |
| 757 | PKM2 | E8a_E10a (S1) | 11.89 | 43.40% | AC100778.5 | E4a_E5a (S0) | 11.67 | 57.76% |
| 758 | DCN | E8a_E9a (S0) | 11.89 | 60.96% | HNRPA2B1 | E11a_E12a (S0) | 11.67 | 64.80% |
| 759 | EIF3EIP | E6a_E7a (S0) | 11.89 | 58.85% | UQCRQ | E1c_E2a (S0) | 11.67 | 461.23% |
| 760 | HNRNPA1 | E4a_E5a (S0) | 11.89 | 57.24% | CLU | E5b_E6a (S0) | 11.67 | 46.48% |
| 761 | EIF3EIP | E4a_E5a (S0) | 11.89 | 58.84% | GDI2 | E12a_E13a (S0) | 11.67 | 54.18% |
| 762 | NAP1L1 | E9a_E10a (S0) | 11.88 | 68.70% | CTSH | E4a_E5a (S0) | 11.67 | 48.19% |
| 763 | RPL13A | E8a_E9a (S0) | 11.88 | 14.31% | RAN | E6a_E7a (S0) | 11.67 | 81.30% |
| 764 | CAP1 | E3b_E4a (S0) | 11.88 | 58.33% | EIF3I | E1a_E2a (S0) | 11.67 | 101.78% |
| 765 | PTPRC | E15a_E16a (S0) | 11.88 | 46.59% | PTPRC | E15a_E16a (S0) | 11.66 | 41.78% |
| 766 | FCER2 | E9a_E10a (S0) | 11.88 | 38.91% | CLU | E1a_E3a (S1) | 11.66 | 46.24% |
| 767 | RAC2 | E5a_E6a (S0) | 11.88 | 38.32% | TAGLN2 | E4a_E5a (S0) | 11.66 | 63.13% |
| 768 | GDI2 | E7a_E8a (S0) | 11.87 | 60.57% | CD81 | E8a_E9a (S0) | 11.66 | 79.11% |
| 769 | CORO1A | E10a_E11a (S0) | 11.87 | 22.45% | ANXA2 | E1a_E3a (S1) | 11.66 | 111.95% |
| 770 | TPM3 | E10a_E11a (S0) | 11.87 | 252.78% | CHCHD2 | E3a_E4a (S0) | 11.66 | 54.75% |
| 771 | CALM1 | E2a_E3a (S0) | 11.87 | 129.07% | PTMA | E5a_E6a (S0) | 11.66 | 28.88% |
| 772 | PTPRC | E24a_E25a (S0) | 11.86 | 46.08% | GDI2 | E13a_E14a (S0) | 11.65 | 53.64% |
| 773 | GDI2 | E8b_E9a (S0) | 11.86 | 60.15% | ACTR3 | E10a_E11a (S0) | 11.65 | 46.13% |
| 774 | PTPRC | E13a_E14a (S0) | 11.86 | 45.98% | ACTR3 | E4a_E5a (S0) | 11.65 | 46.13% |
| 775 | PTPRC | E14a_E15a (S0) | 11.86 | 45.97% | HNRNPK | E10a_E11a (S0) | 11.65 | 74.43% |
| 776 | HSP90AB1 | E4a_E5a (S0) | 11.86 | 38.70% | IGFBP7 | E4a_E5a (S0) | 11.65 | 86.30% |
| 777 | MSN | E10a_E11a (S0) | 11.86 | 36.94% | EVI2B | E1a_E2a (S0) | 11.65 | 40.65% |
| 778 | UCP2 | E3a_E4a (S0) | 11.86 | 37.24% | PCBP2 | E2a_E3a (S0) | 11.65 | 40.37% |
| 779 | VIL2 | E12a_E13a (S0) | 11.85 | 41.66% | HSPA8 | E2a_E3a (S0) | 11.65 | 13.20% |
| 780 | CTSB | E6a_E7a (S0) | 11.85 | 57.96% | PSME1 | E8a_E9a (S0) | 11.64 | 54.66% |
| 781 | LDHA | E2a_E3a (S0) | 11.85 | 65.41% | EIF3K | E3a_E4a (S0) | 11.64 | 70.69% |
| 782 | HNRPA2B1 | E3a_E4a (S0) | 11.85 | 67.63% | PKM2 | E5a_E6a (S0) | 11.63 | 43.82% |
| 783 | ACTR3 | E8a_E9a (S0) | 11.85 | 45.24% | ARHGDIA | E1a_E2a (S0) | 11.63 | 162.12% |
| 784 | AF235103.4 | E4a_E5a (S0) | 11.85 | 16.63% | LRMP | E20a_E21a (S0) | 11.63 | 54.73% |
| 785 | COX6A1 | E2a_E3a (S0) | 11.85 | 112.07% | EEF1B2 | E3a_E4a (S0) | 11.63 | 43.97% |
| 786 | SLC25A3 | E6a_E7a (S0) | 11.84 | 86.65% | RGS1 | E3a_E4a (S0) | 11.62 | 36.10% |
| 787 | ATP2A3 | E17a_E18a (S0) | 11.84 | 56.92% | ANXA2 | E11a_E12a (S0) | 11.62 | 109.06% |
| 788 | DDX5 | E4a_E5a (S0) | 11.84 | 35.62% | EEF1B2 | E4a_E5a (S0) | 11.62 | 43.75% |
| 789 | NAP1L1 | E4a_E5a (S0) | 11.84 | 66.71% | RPL24 | E5a_E6a (S0) | 11.62 | 7.64% |
| 790 | TAGLN2 | E6a_E7a (S0) | 11.84 | 59.53% | PHB2 | E5a_E6a (S0) | 11.62 | 52.45% |
| 791 | ACTR2 | E5a_E6a (S0) | 11.84 | 59.35% | PCBP2 | E10a_E11a (S0) | 11.62 | 39.52% |
| 792 | ACTR3 | E9a_E10a (S0) | 11.84 | 44.83% | VIL2 | E7a_E8a (S0) | 11.61 | 51.75% |
| 793 | TXNIP | E4a_E5a (S0) | 11.83 | 39.99% | ENO1 | E9a_E10a (S0) | 11.61 | 38.98% |
| 794 | GNB2L1 | E7a_E8a (S0) | 11.83 | 8.60% | EIF4A2 | E6a_E7a (S0) | 11.61 | 42.54% |
| 795 | CALR | E3a_E4a (S0) | 11.82 | 54.89% | NDUFA3 | E2a_E3a (S0) | 11.61 | 231.16% |
| 796 | RAC2 | E2a_E4a (S1) | 11.82 | 36.85% | HSP90AA1 | E4a_E5a (S0) | 11.61 | 74.93% |
| 797 | ARPC2 | E4a_E5a (S0) | 11.82 | 40.98% | RPL18 | E2a_E3a (S0) | 11.61 | 8.16% |
| 798 | TMBIM6 | E4a_E5a (S0) | 11.82 | 34.19% | PTPRC | E13a_E14a (S0) | 11.61 | 40.16% |
| 799 | ALDOA | E11a_E12a (S0) | 11.82 | 67.89% | RAN | E4a_E6a (S1) | 11.61 | 77.96% |
| 800 | ACTA2 | E1a_E2a (S0) | 11.81 | 140.62% | SET | E6a_E7a (S0) | 11.60 | 105.02% |
| 801 | HNRNPH2 | E2a_E3a (S0) | 11.81 | 108.81% | PKM2 | E2b_E3a (S0) | 11.60 | 42.89% |
| 802 | LIMD2 | E4a_E5a (S0) | 11.81 | 100.68% | ALDOA | E12a_E13a (S0) | 11.60 | 74.07% |
| 803 | MSN | E13a_E14a (S0) | 11.81 | 35.70% | NAP1L1 | E10a_E11a (S0) | 11.60 | 55.60% |
| 804 | PCBP2 | E5a_E6a (S0) | 11.80 | 46.91% | UQCR | E2a_E3a (S0) | 11.60 | 195.42% |
| 805 | CXCL9 | E2a_E3a (S0) | 11.80 | 78.94% | GGA2 | E6a_E7a (S0) | 11.60 | 66.16% |
| 806 | EIF3K | E2a_E3a (S0) | 11.80 | 97.94% | EIF4G2 | E10a_E11a (S0) | 11.60 | 41.13% |
| 807 | ANXA2 | E13a_E14a (S0) | 11.80 | 82.73% | MIF | E1a_E2a (S0) | 11.60 | 87.10% |
| 808 | HLA-DMA | E3a_E4a (S0) | 11.80 | 46.89% | AP001453.6 | E2a_E3a (S0) | 11.59 | 84.51% |
| 809 | HLA-DQA2 | E3a_E4a (S0) | 11.80 | 94.62% | TRDV2 | E2a_E3a (S0) | 11.59 | 58.95% |
| 810 | DDX5 | E5a_E6a (S0) | 11.80 | 34.55% | PTPRC | E10a_E11a (S0) | 11.59 | 39.82% |
| 811 | RPS19 | E4a_E5a (S0) | 11.80 | 18.85% | EIF4G2 | E8a_E9a (S0) | 11.59 | 40.91% |
| 812 | EIF3EIP | E9a_E10a (S0) | 11.79 | 55.20% | TUBB | E3a_E4a (S0) | 11.59 | 42.98% |
| 813 | CST3 | E2a_E3a (S0) | 11.79 | 107.16% | CD37 | E1a_E2a (S0) | 11.59 | 17.08% |
| 814 | MMP9 | E7a_E8a (S0) | 11.79 | 54.44% | EIF4G2 | E18a_E19a (S0) | 11.58 | 40.70% |
| 815 | ALDOA | E13a_E14a (S0) | 11.79 | 66.64% | SEPT9 | E11a_E12a (S0) | 11.58 | 110.14% |
| 816 | TMBIM6 | E9a_E10a (S0) | 11.79 | 33.55% | UBE2D3 | E10a_E12a (S2) | 11.58 | 99.88% |
| 817 | AF235103.4 | E3a_E4a (S0) | 11.79 | 15.98% | EEF1D | E8a_E9a (S0) | 11.58 | 99.35% |
| 818 | SELL | E5a_E6a (S0) | 11.79 | 39.41% | ATP5B | E3a_E4a (S0) | 11.58 | 48.13% |
| 819 | EIF3E | E10a_E11a (S0) | 11.79 | 44.03% | YWHAZ | E7a_E8a (S0) | 11.57 | 50.91% |
| 820 | PTMA | E5a_E6a (S0) | 11.79 | 33.73% | ARPC5 | E3a_E4a (S0) | 11.57 | 42.09% |
| 821 | COL1A2 | E53a_E54a (S0) | 11.79 | 67.06% | ALDOA | E11a_E12a (S0) | 11.57 | 72.69% |
| 822 | RPS27 | E3c_E4a (S0) | 11.79 | 8.31% | TCL1A | E2a_E3a (S0) | 11.57 | 30.34% |
| 823 | ENO1 | E7a_E8a (S0) | 11.78 | 33.77% | RHOA | E2a_E3a (S0) | 11.57 | 27.73% |
| 824 | CALM1 | E4a_E5a (S0) | 11.78 | 121.84% | PSAP | E2a_E3a (S0) | 11.57 | 63.69% |
| 825 | PCBP2 | E3a_E4a (S0) | 11.78 | 46.23% | CCNI | E6a_E7a (S0) | 11.57 | 46.81% |
| 826 | FN1 | E45a_E46a (S0) | 11.78 | 68.67% | FXYD5 | E2a_E3a (S0) | 11.57 | 218.77% |
| 827 | SEPT9 | E7a_E8a (S0) | 11.78 | 85.63% | FTH1 | E3a_E4a (S0) | 11.57 | 38.89% |
| 828 | TPP1 | E1a_E2a (S0) | 11.78 | 94.55% | COX6C | E2a_E3a (S0) | 11.57 | 42.12% |
| 829 | RPS13 | E4a_E5a (S0) | 11.78 | 12.94% | RPS9 | E2a_E3a (S0) | 11.57 | 24.80% |
| 830 | PTPRC | E10a_E11a (S0) | 11.78 | 43.37% | PTGDS | E4a_E5a (S0) | 11.57 | 68.80% |
| 831 | HLA-DQA1 | E4a_E4b (S0) | 11.77 | 67.22% | TPM3 | E11a_E14b (S5) | 11.56 | 267.84% |
| 832 | AP005329.2 | E5a_E6a (S0) | 11.77 | 81.40% | DDX17 | E3a_E4a (S0) | 11.56 | 45.51% |
| 833 | DCN | E6a_E7a (S0) | 11.77 | 56.12% | EIF3H | E5a_E6a (S0) | 11.56 | 41.64% |
| 834 | MYL6 | E5a_E7a (S2) | 11.77 | 24.00% | NPM1 | E4a_E5a (S0) | 11.56 | 34.08% |
| 835 | UBA52 | E3a_E4a (S0) | 11.77 | 17.36% | CORO1A | E2a_E3a (S0) | 11.56 | 20.46% |
| 836 | LCP1 | E4a_E5a (S0) | 11.77 | 19.74% | CD22 | E10a_E11a (S0) | 11.56 | 40.39% |
| 837 | YWHAB | E5a_E6a (S0) | 11.77 | 55.96% | ATP2A3 | E12a_E13a (S0) | 11.55 | 30.38% |
| 838 | TXNIP | E6a_E7a (S0) | 11.77 | 38.34% | CAPZB | E10a_E11a (S0) | 11.55 | 97.15% |
| 839 | EIF4G2 | E5a_E6a (S0) | 11.77 | 33.46% | ARPC1B | E3a_E4a (S0) | 11.55 | 63.49% |
| 840 | TAGLN2 | E5a_E6a (S0) | 11.76 | 56.65% | CCNI | E4a_E5a (S0) | 11.55 | 46.29% |
| 841 | HNRNPK | E9a_E10a (S0) | 11.76 | 61.76% | RPL13A | E3a_E4a (S0) | 11.55 | 5.77% |
| 842 | HSP90AB1 | E7a_E8a (S0) | 11.76 | 36.25% | TMBIM6 | E3a_E4a (S0) | 11.55 | 44.34% |
| 843 | FCER2 | E6a_E7a (S0) | 11.76 | 35.89% | CD48 | E3a_E4a (S0) | 11.55 | 65.16% |
| 844 | IL2RG | E3a_E4a (S0) | 11.76 | 40.14% | RGS1 | E4a_E5a (S0) | 11.55 | 34.27% |
| 845 | HNRPA2B1 | E9a_E10a (S0) | 11.76 | 63.62% | UBA52 | E1a_E2a (S0) | 11.55 | 11.48% |
| 846 | COL1A2 | E52a_E53a (S0) | 11.76 | 65.80% | CTSH | E8a_E9a (S0) | 11.55 | 44.45% |
| 847 | YWHAB | E4a_E5a (S0) | 11.76 | 55.54% | CSK | E10a_E11a (S0) | 11.55 | 59.85% |
| 848 | TAPBP | E5a_E6a (S0) | 11.76 | 90.94% | MEF2B | E10a_E11a (S0) | 11.54 | 92.56% |
| 849 | HNRNPF | E5a_E6a (S0) | 11.75 | 92.92% | SEPP1 | E3a_E4a (S0) | 11.54 | 94.40% |
| 850 | CD44 | E4a_E5a (S0) | 11.75 | 110.36% | PTPRC | E12b_E13a (S0) | 11.54 | 38.43% |
| 851 | ENO1 | E2a_E3a (S0) | 11.75 | 33.12% | CD81 | E9a_E10a (S0) | 11.54 | 72.77% |
| 852 | RPL14 | E4a_E5a (S0) | 11.75 | 30.43% | CCNI | E3a_E4a (S0) | 11.54 | 45.78% |
| 853 | BTF3 | E2a_E3a (S0) | 11.75 | 40.97% | HSP90AB1 | E3a_E4a (S0) | 11.54 | 45.61% |
| 854 | RPS24 | E3a_E4a (S0) | 11.75 | 18.77% | RGS1 | E2a_E3a (S0) | 11.53 | 33.89% |
| 855 | PTPRC | E9b_E10a (S0) | 11.75 | 42.65% | EIF3F | E4a_E5a (S0) | 11.53 | 153.10% |
| 856 | TXNIP | E5a_E6a (S0) | 11.75 | 37.87% | EIF3EIP | E3a_E4a (S0) | 11.53 | 49.96% |
| 857 | HSP90AB1 | E9a_E10a (S0) | 11.75 | 35.91% | ENO1 | E7a_E8a (S0) | 11.53 | 36.89% |
| 858 | GNAI2 | E4a_E5a (S0) | 11.75 | 33.41% | ACTR3 | E6a_E7a (S0) | 11.53 | 42.51% |
| 859 | IL2RG | E6a_E7a (S0) | 11.75 | 39.77% | EIF3M | E2a_E3a (S0) | 11.53 | 64.77% |
| 860 | C4orf7 | E3a_E4a (S0) | 11.75 | 13.41% | HMGN2 | E2a_E3a (S0) | 11.53 | 30.61% |
| 861 | EIF3H | E4a_E5a (S0) | 11.74 | 51.14% | DDX17 | E7a_E8a (S0) | 11.52 | 44.26% |
| 862 | COL1A1 | E49a_E50a (S0) | 11.74 | 55.60% | HNRNPK | E6a_E7b (S0) | 11.52 | 68.20% |
| 863 | NAP1L1 | E12a_E13a (S0) | 11.74 | 62.30% | GABARAP | E3a_E4a (S0) | 11.52 | 45.85% |
| 864 | EIF3EIP | E8a_E9a (S0) | 11.74 | 53.25% | HNRNPH2 | E2a_E3a (S0) | 11.52 | 89.15% |
| 865 | H3F3B | E2a_E3a (S0) | 11.74 | 83.51% | ATP5B | E7a_E8a (S0) | 11.52 | 46.14% |
| 866 | SLC25A6 | E1a_E2a (S0) | 11.74 | 32.55% | GNAI2 | E4a_E5a (S0) | 11.52 | 37.27% |
| 867 | HSP90AB1 | E10a_E11a (S0) | 11.74 | 35.63% | HSP90AB1 | E12a_E13a (S0) | 11.51 | 44.85% |
| 868 | CAPZB | E11a_E13a (S2) | 11.73 | 75.11% | YBX1 | E2a_E3a (S0) | 11.51 | 53.28% |
| 869 | CD22 | E13a_E14a (S0) | 11.73 | 47.54% | PTPRC | E14a_E15a (S0) | 11.51 | 37.68% |
| 870 | EIF3I | E1a_E2a (S0) | 11.73 | 116.38% | EIF4A1 | E7a_E8a (S0) | 11.51 | 149.90% |
| 871 | NPM1 | E4a_E5a (S0) | 11.73 | 44.78% | STAT6 | E19a_E20a (S0) | 11.51 | 65.09% |
| 872 | HNRNPK | E7a_E8a (S0) | 11.73 | 60.41% | POU2AF1 | E5a_E6a (S0) | 11.51 | 53.99% |
| 873 | CALR | E6a_E7a (S0) | 11.73 | 51.44% | EIF4G2 | E9a_E10a (S0) | 11.51 | 38.70% |
| 874 | PTPRC | E11a_E12a (S0) | 11.73 | 41.93% | HNRPA2B1 | E7b_E8a (S0) | 11.51 | 57.79% |
| 875 | LSP1 | E8a_E9a (S0) | 11.73 | 156.08% | HMGN1 | E4a_E5a (S0) | 11.51 | 76.11% |
| 876 | CCNI | E6a_E7a (S0) | 11.73 | 37.12% | CD22 | E8a_E9a (S0) | 11.51 | 38.94% |
| 877 | APOE | E3a_E4a (S0) | 11.72 | 32.84% | ARPC3 | E2a_E3a (S0) | 11.51 | 20.91% |
| 878 | ANXA2 | E9a_E10a (S0) | 11.72 | 78.43% | RBM3 | E1a_E2b (S0) | 11.50 | 77.67% |
| 879 | SLC25A3 | E5a_E6a (S0) | 11.72 | 79.55% | SNRPD2 | E1a_E3a (S1) | 11.50 | 53.58% |
| 880 | CAPNS1 | E8a_E9a (S0) | 11.72 | 90.77% | EIF3E | E12a_E13a (S0) | 11.50 | 21.42% |
| 881 | ATP2A3 | E18a_E19a (S0) | 11.71 | 52.00% | DDX17 | E10a_E11a (S0) | 11.50 | 43.63% |
| 882 | CCNI | E2a_E3a (S0) | 11.71 | 36.67% | PKM2 | E4a_E5a (S0) | 11.50 | 40.00% |
| 883 | LYZ | E3a_E4a (S0) | 11.71 | 36.65% | SNRPG | E3a_E4a (S0) | 11.50 | 81.18% |
| 884 | MSN | E8a_E9a (S0) | 11.71 | 33.29% | CAPZB | E8a_E9a (S0) | 11.50 | 93.38% |
| 885 | PPP1CA | E5a_E6a (S0) | 11.70 | 61.52% | EIF3EIP | E7a_E8a (S0) | 11.50 | 48.80% |
| 886 | HNRPA2B1 | E10a_E11a (S0) | 11.70 | 61.19% | ARPC2 | E2a_E3a (S0) | 11.50 | 31.42% |
| 887 | FCER2 | E11a_E12a (S0) | 11.70 | 34.49% | C4orf34 | E3a_E4a (S0) | 11.49 | 45.30% |
| 888 | TMBIM6 | E6a_E7a (S0) | 11.70 | 31.50% | HNRNPK | E11a_E12a (S0) | 11.49 | 66.83% |
| 889 | SLC25A3 | E4a_E5a (S0) | 11.70 | 78.54% | ATP5B | E6a_E7a (S0) | 11.49 | 45.23% |
| 890 | CD81 | E7a_E8a (S0) | 11.70 | 53.37% | NAP1L1 | E14a_E15a (S0) | 11.49 | 51.41% |
| 891 | DDX5 | E11a_E12a (S0) | 11.70 | 32.28% | ATP5H | E1a_E2a (S0) | 11.49 | 112.35% |
| 892 | PLEK | E2a_E3a (S0) | 11.69 | 51.83% | ATP2A3 | E8a_E9a (S0) | 11.49 | 29.02% |
| 893 | RPS7 | E5a_E6a (S0) | 11.69 | 46.20% | COX4I1 | E1a_E2a (S0) | 11.48 | 29.03% |
| 894 | UBL5 | E3a_E4a (S0) | 11.68 | 91.91% | EIF4G2 | E7a_E8a (S0) | 11.48 | 37.92% |
| 895 | IGHG2 | E1b_E2a (S0) | 11.68 | 50.27% | GDI2 | E10a_E11a (S0) | 11.48 | 47.51% |
| 896 | RPL15 | E2a_E3a (S0) | 11.68 | 29.10% | MOBKL1B | E6a_E7a (S0) | 11.48 | 78.33% |
| 897 | CD81 | E5a_E6a (S0) | 11.68 | 52.44% | CDC42 | E7a_E9a (S1) | 11.48 | 106.45% |
| 898 | RPL35 | E2a_E3a (S0) | 11.68 | 18.24% | CTSH | E11a_E12a (S0) | 11.48 | 42.23% |
| 899 | GDI2 | E12a_E13a (S0) | 11.67 | 52.73% | CALR | E6a_E7a (S0) | 11.48 | 53.64% |
| 900 | PKM2 | E4a_E5a (S0) | 11.67 | 37.23% | CD52 | E1a_E2a (S0) | 11.47 | 8.64% |
| 901 | EVI2B | E1a_E2a (S0) | 11.67 | 30.63% | TSC22D3 | E5a_E6a (S0) | 11.47 | 60.83% |
| 902 | HSP90AA1 | E6a_E7a (S0) | 11.67 | 49.96% | ATP2A3 | E4a_E5a (S0) | 11.47 | 28.69% |
| 903 | HSP90AA1 | E10a_E11a (S0) | 11.67 | 49.96% | SLC25A3 | E3a_E4a (S0) | 11.47 | 53.03% |
| 904 | TXNIP | E2a_E3a (S0) | 11.67 | 35.85% | DDX17 | E8a_E9a (S0) | 11.47 | 42.73% |
| 905 | RPL35A | E4a_E5a (S0) | 11.67 | 8.21% | EIF4G2 | E17a_E18a (S0) | 11.47 | 37.58% |
| 906 | ATP5B | E3a_E4a (S0) | 11.67 | 48.78% | CLIC1 | E7a_E8a (S0) | 11.47 | 75.52% |
| 907 | GABARAP | E3a_E4a (S0) | 11.67 | 34.11% | TPI1 | E5b_E6a (S0) | 11.46 | 84.69% |
| 908 | AC069236.27 | E5a_E6a (S0) | 11.67 | 109.11% | HNRNPH1 | E7a_E8a (S0) | 11.46 | 96.06% |
| 909 | LYZ | E2a_E3a (S0) | 11.66 | 35.56% | CAPZA1 | E5a_E6a (S0) | 11.46 | 80.16% |
| 910 | ALOX5AP | E2a_E3a (S0) | 11.66 | 62.42% | TPM3 | E8a_E10a (S1) | 11.46 | 249.27% |
| 911 | CALR | E4a_E5a (S0) | 11.66 | 49.17% | ATP5A1 | E5a_E6a (S0) | 11.46 | 47.84% |
| 912 | GDI2 | E13a_E14a (S0) | 11.66 | 52.31% | USF2 | E6a_E7a (S0) | 11.46 | 108.26% |
| 913 | PLA2G2D | E2a_E3a (S0) | 11.66 | 61.71% | ATP2A3 | E5a_E6a (S0) | 11.46 | 28.42% |
| 914 | EIF4A1 | E7a_E8a (S0) | 11.66 | 142.89% | RGS10 | E3a_E4a (S0) | 11.45 | 97.66% |
| 915 | DCN | E7a_E8a (S0) | 11.66 | 51.81% | PTPRC | E8a_E9a (S0) | 11.45 | 36.05% |
| 916 | UCP2 | E4a_E5a (S0) | 11.66 | 32.46% | RP4-604K5.1 | E5a_E6a (S0) | 11.45 | 75.29% |
| 917 | PTPRC | E12b_E13a (S0) | 11.65 | 39.87% | DDX17 | E4a_E5a (S0) | 11.44 | 41.86% |
| 918 | ACTR3 | E10a_E11a (S0) | 11.65 | 39.50% | EIF4G2 | E19a_E20a (S0) | 11.44 | 36.91% |
| 919 | CAPG | E5a_E6a (S0) | 11.65 | 121.10% | C4orf7 | E3a_E4a (S0) | 11.44 | 17.72% |
| 920 | EIF3EIP | E7a_E8a (S0) | 11.65 | 50.08% | TMBIM6 | E7a_E8a (S0) | 11.44 | 41.11% |
| 921 | TRAPPC1 | E3a_E4a (S0) | 11.65 | 77.15% | HNRPA2B1 | E10a_E11a (S0) | 11.44 | 55.16% |
| 922 | CAP1 | E6a_E8a (S1) | 11.65 | 49.65% | TMBIM6 | E5a_E6a (S0) | 11.44 | 41.11% |
| 923 | TCEB2 | E1a_E2b (S0) | 11.65 | 289.54% | C4orf7 | E4a_E5a (S0) | 11.44 | 17.72% |
| 924 | CD53 | E3a_E4a (S0) | 11.65 | 34.07% | HSP90AB1 | E4a_E5a (S0) | 11.44 | 42.54% |
| 925 | CTSC | E8a_E9a (S0) | 11.65 | 48.21% | EEF1D | E7a_E8a (S0) | 11.44 | 89.85% |
| 926 | GLTSCR2 | E3a_E4a (S0) | 11.64 | 51.65% | GGA2 | E9a_E10a (S0) | 11.44 | 59.15% |
| 927 | PLEK | E8a_E9a (S0) | 11.64 | 50.00% | CD83 | E3a_E4a (S0) | 11.43 | 51.73% |
| 928 | MSN | E9a_E10a (S0) | 11.64 | 31.78% | ATP5B | E9a_E10a (S0) | 11.43 | 43.51% |
| 929 | EIF3H | E5a_E6a (S0) | 11.64 | 47.51% | VIL2 | E11a_E12a (S0) | 11.43 | 45.66% |
| 930 | SEPT9 | E9a_E10a (S0) | 11.64 | 77.51% | CCNI | E5a_E6a (S0) | 11.43 | 42.54% |
| 931 | TXNIP | E3a_E4a (S0) | 11.64 | 35.03% | ACTR3 | E9a_E10a (S0) | 11.43 | 39.63% |
| 932 | CTSC | E7a_E8a (S0) | 11.64 | 47.91% | HNRNPK | E8a_E9a (S0) | 11.43 | 63.94% |
| 933 | MGP | E3a_E4a (S0) | 11.63 | 332.77% | LIMD2 | E4a_E5a (S0) | 11.42 | 75.62% |
| 934 | FCER2 | E5a_E6a (S0) | 11.63 | 32.86% | CD53 | E1a_E2a (S0) | 11.42 | 32.91% |
| 935 | LSP1 | E11a_E12a (S0) | 11.63 | 146.38% | TAGLN2 | E6a_E7a (S0) | 11.42 | 53.50% |
| 936 | EEF1D | E7a_E8a (S0) | 11.63 | 87.00% | CCT7 | E2a_E3a (S0) | 11.42 | 112.45% |
| 937 | CAP1 | E12a_E13a (S0) | 11.63 | 48.89% | PARK7 | E4a_E5a (S0) | 11.42 | 87.09% |
| 938 | HLA-DMB | E2a_E3a (S0) | 11.63 | 40.20% | SEPT9 | E6a_E7a (S0) | 11.42 | 98.38% |
| 939 | EIF3EIP | E2a_E3a (S0) | 11.62 | 49.09% | HNRNPH1 | E5a_E6a (S0) | 11.42 | 93.19% |
| 940 | FN1 | E31a_E32a (S0) | 11.62 | 61.52% | RPL27A | E2a_E3a (S0) | 11.41 | 80.59% |
| 941 | GNAI2 | E9a_E10a (S0) | 11.62 | 30.64% | SEPT9 | E9a_E10a (S0) | 11.41 | 98.09% |
| 942 | ATP2A3 | E16a_E17a (S0) | 11.62 | 48.77% | RBM3 | E6a_E7a (S0) | 11.41 | 72.94% |
| 943 | UBL5 | E4a_E5a (S0) | 11.62 | 87.94% | NAPSB | E2a_E3a (S0) | 11.41 | 56.02% |
| 944 | EEF1D | E8a_E9a (S0) | 11.62 | 86.31% | CLIC1 | E8a_E9a (S0) | 11.41 | 72.61% |
| 945 | EIF3E | E8a_E9a (S0) | 11.62 | 39.23% | SERF2 | E4a_E5c (S0) | 11.41 | 182.80% |
| 946 | NPC2 | E2a_E3a (S0) | 11.62 | 61.23% | RBM3 | E7a_E7b (S0) | 11.41 | 72.53% |
| 947 | RPL27 | E4a_E5a (S0) | 11.62 | 8.97% | TPM3 | E3b_E5a (S1) | 11.41 | 240.39% |
| 948 | HNRPA2B1 | E8a_E9a (S0) | 11.62 | 57.52% | PPP1CA | E3a_E4a (S0) | 11.41 | 46.42% |
| 949 | AC008155.10 | E2a_E3a (S0) | 11.61 | 14925.33% | S100A4 | E5a_E6a (S0) | 11.40 | 157.69% |
| 950 | HNRNPK | E16a_E17a (S0) | 11.61 | 55.65% | HLA-DMA | E3a_E4a (S0) | 11.40 | 34.56% |
| 951 | MSN | E5a_E6a (S0) | 11.61 | 31.19% | NDUFB11 | E1a_E2a (S0) | 11.40 | 257.71% |
| 952 | SNRPB | E2a_E3a (S0) | 11.61 | 129.67% | CAPZA1 | E9a_E10a (S0) | 11.40 | 77.03% |
| 953 | ACTR3 | E5a_E6a (S0) | 11.61 | 38.27% | LTB | E3a_E4a (S0) | 11.40 | 43.49% |
| 954 | RPSA | E4a_E5a (S0) | 11.61 | 49.11% | CLU | E4a_E5a (S0) | 11.40 | 38.48% |
| 955 | HMGB1 | E4b_E5a (S0) | 11.60 | 167.98% | CLU | E6b_E7a (S0) | 11.40 | 38.48% |
| 956 | CTSD | E2a_E3a (S0) | 11.60 | 49.02% | HSPE1 | E2a_E3a (S0) | 11.39 | 133.68% |
| 957 | GSTP1 | E6a_E7a (S0) | 11.60 | 76.82% | EIF4G2 | E13a_E14a (S0) | 11.39 | 35.69% |
| 958 | EIF3F | E5a_E6a (S0) | 11.60 | 186.19% | RPLP2 | E1a_E2a (S0) | 11.39 | 4.57% |
| 959 | ACTR2 | E7a_E8a (S0) | 11.60 | 50.38% | SRP14 | E4a_E5a (S0) | 11.39 | 31.34% |
| 960 | SPARC | E3a_E4a (S0) | 11.60 | 33.01% | CSK | E7a_E8a (S0) | 11.39 | 53.79% |
| 961 | HCLS1 | E11a_E12a (S0) | 11.60 | 50.51% | HNRPA2B1 | E6b_E7a (S0) | 11.39 | 53.19% |
| 962 | S100A6 | E1b_E3a (S1) | 11.60 | 192.87% | PTPRC | E9b_E10a (S0) | 11.38 | 34.43% |
| 963 | CTSD | E7a_E8a (S0) | 11.60 | 48.88% | C14orf2 | E2a_E3a (S0) | 11.38 | 87.49% |
| 964 | ATP2A3 | E14a_E15a (S0) | 11.60 | 47.99% | MOBKL1B | E2a_E4a (S1) | 11.38 | 73.26% |
| 965 | NACA | E3a_E4a (S0) | 11.59 | 26.33% | HNRNPA1 | E7a_E9a (S1) | 11.38 | 41.08% |
| 966 | VIL2 | E6a_E7a (S0) | 11.59 | 34.78% | HSP90AB1 | E8a_E9a (S0) | 11.38 | 40.86% |
| 967 | CAP1 | E1b_E2b (S0) | 11.59 | 47.58% | CD22 | E6a_E7a (S0) | 11.38 | 35.68% |
| 968 | EIF4A1 | E10a_E10b (S0) | 11.59 | 135.86% | HSP90AA1 | E12a_E13a (S0) | 11.38 | 63.88% |
| 969 | RPLP0 | E1a_E2a (S0) | 11.59 | 9.04% | RAC2 | E4a_E5a (S0) | 11.38 | 31.26% |
| 970 | NAP1L1 | E14a_E15a (S0) | 11.58 | 55.89% | HNRNPK | E7a_E8a (S0) | 11.38 | 61.79% |
| 971 | GPX4 | E6a_E7a (S0) | 11.58 | 60.86% | TMBIM6 | E6a_E7a (S0) | 11.37 | 39.26% |
| 972 | MSN | E7a_E8a (S0) | 11.58 | 30.53% | CIITA | E10b_E11a (S0) | 11.37 | 124.97% |
| 973 | ATP2A3 | E10a_E11a (S0) | 11.58 | 47.46% | YBX1 | E4a_E5a (S0) | 11.37 | 48.24% |
| 974 | CALM2 | E6a_E7a (S0) | 11.58 | 44.57% | HSP90AB1 | E7a_E8a (S0) | 11.37 | 40.61% |
| 975 | DDX5 | E3a_E4a (S0) | 11.58 | 29.66% | CD83 | E4a_E5a (S0) | 11.37 | 49.53% |
| 976 | SELL | E3a_E4a (S0) | 11.57 | 34.00% | HNRPA2B1 | E3a_E4a (S0) | 11.37 | 52.36% |
| 977 | ATP5B | E4a_E5a (S0) | 11.57 | 45.43% | RPL38 | E2a_E3a (S0) | 11.37 | 5.95% |
| 978 | EIF3F | E3a_E4a (S0) | 11.57 | 181.86% | PSME1 | E3a_E4a (S0) | 11.37 | 45.21% |
| 979 | DDX5 | E6a_E7a (S0) | 11.57 | 29.44% | SEPT9 | E8a_E9a (S0) | 11.37 | 94.79% |
| 980 | EIF4G2 | E21c_E22a (S0) | 11.56 | 29.05% | HLA-DMB | E4a_E5a (S0) | 11.37 | 29.84% |
| 981 | EIF3EIP | E3a_E4a (S0) | 11.56 | 47.00% | ATP5A1 | E7a_E8a (S0) | 11.36 | 44.84% |
| 982 | ATP5B | E6a_E7a (S0) | 11.56 | 45.17% | NEDD8 | E4a_E5a (S0) | 11.36 | 73.17% |
| 983 | CD79B | E2a_E3a (S0) | 11.56 | 23.60% | ENO1 | E11a_E12a (S0) | 11.36 | 32.80% |
| 984 | RAB7A | E2a_E3a (S0) | 11.56 | 84.70% | NONO | E7a_E8a (S0) | 11.36 | 63.46% |
| 985 | FXYD5 | E2a_E3a (S0) | 11.56 | 172.83% | NDUFA1 | E2a_E3a (S0) | 11.36 | 63.50% |
| 986 | MYH9 | E13a_E14a (S0) | 11.56 | 50.67% | PSAP | E13a_E14a (S0) | 11.36 | 54.91% |
| 987 | CSK | E10a_E11a (S0) | 11.56 | 56.12% | PSAP | E10a_E11a (S0) | 11.35 | 54.75% |
| 988 | TPM3 | E7a_E8b (S0) | 11.56 | 203.56% | SFRS5 | E6b_E7a (S0) | 11.35 | 54.80% |
| 989 | ALDOA | E15a_E16a (S0) | 11.56 | 56.58% | COX6B1 | E3a_E4a (S0) | 11.35 | 55.44% |
| 990 | FCER2 | E4a_E5a (S0) | 11.56 | 31.12% | VIL2 | E12a_E13a (S0) | 11.35 | 43.17% |
| 991 | RPSA | E2a_E3a (S0) | 11.55 | 47.31% | CD22 | E9a_E10a (S0) | 11.35 | 34.99% |
| 992 | FN1 | E42a_E43a (S0) | 11.55 | 58.58% | PHB2 | E6a_E7a (S0) | 11.35 | 43.51% |
| 993 | RPL24 | E4a_E5a (S0) | 11.55 | 13.30% | VIL2 | E8a_E9a (S0) | 11.35 | 43.03% |
| 994 | BTF3 | E3a_E4a (S0) | 11.55 | 35.69% | ATP5A1 | E11a_E12a (S0) | 11.35 | 44.28% |
| 995 | ATP2A3 | E7a_E8a (S0) | 11.55 | 46.54% | PPP1CA | E5a_E6a (S0) | 11.35 | 44.56% |
| 996 | CD53 | E5a_E6a (S0) | 11.55 | 31.84% | NDUFB1 | E2a_E3a (S0) | 11.34 | 76.51% |
| 997 | RNASE1 | E1a_E3a (S2) | 11.55 | 106.73% | CNN2 | E2a_E3a (S0) | 11.34 | 88.96% |
| 998 | EIF4B | E12a_E13a (S0) | 11.55 | 60.50% | ATP5A1 | E6a_E7a (S0) | 11.34 | 44.01% |
| 999 | HNRNPA1 | E6a_E7a (S0) | 11.55 | 45.24% | HNRNPA1 | E4a_E5a (S0) | 11.34 | 39.81% |
| 1000 | HSP90AA1 | E5a_E6a (S0) | 11.55 | 45.74% | TIMP1 | E1a_E3a (S1) | 11.34 | 178.68% |
| 1001 | EWSR1 | E4a_E6a (S1) | 11.54 | 133.77% | TMBIM6 | E8a_E9a (S0) | 11.34 | 38.26% |
| 1002 | FXYD5 | E3a_E5a (S1) | 11.54 | 170.90% | PCBP2 | E7a_E8a (S0) | 11.33 | 32.37% |
| 1003 | TRAM1 | E4a_E5a (S0) | 11.54 | 112.64% | CD44 | E4a_E5a (S0) | 11.33 | 89.09% |
| 1004 | ATP2A3 | E15a_E16a (S0) | 11.54 | 46.28% | PCBP2 | E11a_E12a (S0) | 11.33 | 32.36% |
| 1005 | SRP14 | E4a_E5a (S0) | 11.54 | 41.30% | HMGN2 | E5a_E6a (S0) | 11.33 | 26.70% |
| 1006 | VIL2 | E13a_E14a (S0) | 11.54 | 33.62% | EIF4G2 | E12a_E13a (S0) | 11.33 | 34.12% |
| 1007 | RPL23 | E3a_E4a (S0) | 11.54 | 10.59% | SNX3 | E4a_E5a (S0) | 11.32 | 56.56% |
| 1008 | YWHAZ | E9a_E10a (S0) | 11.54 | 37.84% | HNRNPL | E6a_E7a (S0) | 11.32 | 92.93% |
| 1009 | HNRPA2B1 | E6b_E7a (S0) | 11.54 | 54.61% | GMFG | E3a_E4a (S0) | 11.32 | 87.65% |
| 1010 | CSK | E11a_E12a (S0) | 11.54 | 55.50% | STAT6 | E16a_E17a (S0) | 11.32 | 57.08% |
| 1011 | CAP1 | E13a_E14a (S0) | 11.54 | 45.92% | SKP1A | E4a_E5a (S0) | 11.32 | 99.53% |
| 1012 | ACTR3 | E6a_E7a (S0) | 11.54 | 36.44% | EIF3EIP | E2a_E3a (S0) | 11.32 | 43.16% |
| 1013 | CAPZA1 | E8a_E9a (S0) | 11.54 | 74.42% | LRMP | E6a_E7a (S0) | 11.32 | 44.14% |
| 1014 | COL1A1 | E32a_E33a (S0) | 11.53 | 48.02% | AHNAK | E5b_E5d (S0) | 11.32 | 172.51% |
| 1015 | CD63 | E5a_E6a (S0) | 11.53 | 64.13% | AP005329.2 | E4a_E5a (S0) | 11.31 | 45.75% |
| 1016 | NDUFB3 | E1a_E2a (S0) | 11.53 | 195.50% | MKNK2 | E6a_E7a (S0) | 11.31 | 67.51% |
| 1017 | VIL2 | E1a_E2b (S0) | 11.53 | 33.36% | HMGN1 | E6a_E7a (S0) | 11.31 | 66.66% |
| 1018 | BGN | E6a_E7a (S0) | 11.53 | 53.78% | ATP5B | E4a_E5a (S0) | 11.31 | 40.07% |
| 1019 | TXNIP | E1a_E2a (S0) | 11.52 | 32.37% | ATP5A1 | E9a_E10a (S0) | 11.31 | 43.15% |
| 1020 | UBE2D3 | E9a_E10a (S0) | 11.52 | 99.91% | STK17B | E8a_E9a (S0) | 11.31 | 56.73% |
| 1021 | ITGB2 | E5a_E7a (S1) | 11.52 | 64.86% | CYBASC3 | E5a_E6a (S0) | 11.31 | 47.64% |
| 1022 | SOD1 | E2a_E3a (S0) | 11.52 | 126.78% | ITM2B | E4a_E5a (S0) | 11.31 | 62.91% |
| 1023 | PPP1CA | E3a_E4a (S0) | 11.52 | 54.27% | NAP1L1 | E13a_E14a (S0) | 11.31 | 45.40% |
| 1024 | EIF4A1 | E10c_E10d (S0) | 11.52 | 129.95% | SUB1 | E4a_E5a (S0) | 11.31 | 72.29% |
| 1025 | MOBKL1B | E5a_E6a (S0) | 11.52 | 80.98% | DDX5 | E12a_E13a (S0) | 11.30 | 14.05% |
| 1026 | SELL | E2a_E3a (S0) | 11.52 | 32.69% | GDI2 | E11a_E12a (S0) | 11.30 | 42.08% |
| 1027 | RPL13 | E2a_E3a (S0) | 11.52 | 13.56% | ATP5F1 | E4a_E5a (S0) | 11.30 | 75.36% |
| 1028 | PTPRC | E3a_E4a (S0) | 11.51 | 36.20% | HLA-DMA | E4a_E5a (S0) | 11.30 | 32.31% |
| 1029 | IRF8 | E4a_E5a (S0) | 11.51 | 41.85% | UBL5 | E1a_E2a (S0) | 11.30 | 48.06% |
| 1030 | RPS7 | E3a_E4a (S0) | 11.51 | 40.82% | CHCHD2 | E2a_E3a (S0) | 11.30 | 42.84% |
| 1031 | FAIM3 | E3a_E4a (S0) | 11.51 | 60.56% | ACTR3 | E1a_E2a (S0) | 11.30 | 36.37% |
| 1032 | EIF3F | E4a_E5a (S0) | 11.51 | 174.45% | ALDOA | E15a_E16a (S0) | 11.30 | 60.29% |
| 1033 | COL1A1 | E39a_E40a (S0) | 11.50 | 47.08% | CTSH | E5a_E6a (S0) | 11.30 | 37.48% |
| 1034 | FN1 | E23a_E24a (S0) | 11.50 | 56.62% | IRF8 | E4a_E5a (S0) | 11.30 | 38.25% |
| 1035 | RPL34 | E4a_E5a (S0) | 11.50 | 12.63% | SRGN | E2a_E3a (S0) | 11.30 | 24.92% |
| 1036 | CYBB | E12a_E13a (S0) | 11.50 | 60.31% | CTSH | E7a_E8a (S0) | 11.30 | 37.38% |
| 1037 | GRB2 | E6a_E7a (S0) | 11.50 | 71.34% | RPS16 | E1a_E2a (S0) | 11.30 | 5.98% |
| 1038 | CD53 | E2a_E3a (S0) | 11.50 | 30.77% | STK17B | E5a_E6a (S0) | 11.30 | 56.34% |
| 1039 | COX7B | E2a_E3a (S0) | 11.50 | 110.67% | MEF2B | E11a_E12a (S0) | 11.30 | 78.23% |
| 1040 | AES | E7a_E8a (S0) | 11.50 | 82.78% | CALR | E3a_E4a (S0) | 11.30 | 47.33% |
| 1041 | XRCC6 | E4a_E5a (S0) | 11.50 | 80.91% | CIRBP | E2a_E3a (S0) | 11.29 | 59.23% |
| 1042 | CDC42 | E7a_E9a (S1) | 11.50 | 105.47% | NDUFB1 | E1a_E2a (S0) | 11.29 | 73.82% |
| 1043 | YWHAB | E3a_E4a (S0) | 11.50 | 46.29% | ITM2B | E5a_E6a (S0) | 11.29 | 62.10% |
| 1044 | CCT7 | E2a_E3a (S0) | 11.50 | 101.62% | COTL1 | E2a_E3a (S0) | 11.29 | 32.83% |
| 1045 | CDV3 | E3a_E4a (S0) | 11.50 | 70.81% | HLA-A | E4c_E6a (S1) | 11.29 | 23.91% |
| 1046 | CLU | E7a_E8a (S0) | 11.50 | 52.76% | LSP1 | E11a_E12a (S0) | 11.29 | 160.57% |
| 1047 | FAU | E5a_E6a (S0) | 11.50 | 18.54% | PGK1 | E4a_E5a (S0) | 11.29 | 68.07% |